Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_ff_promoter_p_RM_12_79_17			3	0.5	2.45E-04	URM1, MOCS3	tRNA thio-modification [BP], sulfurtransferase activity [MF], tRNA wobble uridine modification [BP]
CG_ff_promoter_p_RM_14_108_2			4	0.5	3.03E-04	HTRA3, ADAMTSL2	negative regulation of transforming growth factor beta receptor signaling pathway [BP]
CG_ff_promoter_p_RM_12_240_10			2	0.5	1.64E-04	SOX11, GATA4, SRSF11, SRSF3, ABT1	enhancer sequence-specific DNA binding [MF], positive regulation of BMP signaling pathway [BP], transcription from RNA polymerase II promoter [BP], embryonic digestive tract morphogenesis [BP], RNA polymerase II regulatory region sequence-specific DNA binding [MF]
CG_ff_promoter_p_RM_12_39_6			1	0.5	1.88E-04	CYP27A1	cholestanetriol 26-monooxygenase activity [MF], cholesterol 26-hydroxylase activity [MF]
CG_ff_promoter_p_RM_12_57_9			2	1.0	4.49E-04	PDXK, DLL3	negative regulation of neurogenesis [BP], vitamin B6 metabolic process [BP], pyridoxal 5'-phosphate salvage [BP], lithium ion binding [MF], pyridoxal kinase activity [MF], pyridoxal phosphate biosynthetic process [BP]
CG_ff_promoter_p_RM_12_22_8			2	0.5	2.88E-04	IKZF1	positive regulation of neutrophil differentiation [BP]
CG_ff_promoter_p_RM_12_37_8			2	1.0	2.06E-04	ARRB2, TGFBR1	regulation of protein ubiquitination [BP], alpha-1A adrenergic receptor binding [MF], follicle-stimulating hormone receptor binding [MF], type 2A serotonin receptor binding [MF]
CG_ff_promoter_p_RM_12_144_9			2	0.5	1.85E-04	PKD2, PCNT, ADD1, PAX2, SLC12A5	multicellular organism growth [BP], metanephric epithelium development [BP], metanephric collecting duct development [BP], mesonephros development [BP], mesonephric duct development [BP], metanephric mesenchyme development [BP], metanephric distal tubule development [BP], mesonephric tubule development [BP], brain morphogenesis [BP], renal tubule morphogenesis [BP]
CG_ff_promoter_p_RM_12_80_12			2	0.5	2.16E-04	GATA3	otic vesicle development [BP]
CG_ff_promoter_p_RM_12_288_15			3	0.5	4.11E-04	DIO3, TOP1	replication fork protection complex [CC], thyroxine 5-deiodinase activity [MF]
CG_ff_promoter_p_RM_18_5_2			2	1.0	2.40E-05	GDA	guanine catabolic process [BP], guanine deaminase activity [MF]
CG_ff_promoter_p_RM_12_20_15			3	1.0	6.79E-05	SETMAR, IQGAP1	positive regulation of double-strand break repair via nonhomologous end joining [BP], negative regulation of dephosphorylation [BP], transposase activity [MF], transposition, DNA-mediated [BP]
CG_ff_promoter_p_RM_18_9_3			2	1.0	1.89E-04	UGT1A8, SLC16A7, ATL1, FMN2, NUS1	pyruvate secondary active transmembrane transporter activity [MF], meiotic chromosome movement towards spindle pole [BP], endoplasmic reticulum membrane [CC]
CG_ff_promoter_p_RM_12_371_19			2	0.5	2.74E-04	GAL, CORT	neuropeptide hormone activity [MF]
CG_ff_promoter_p_RM_14_72_8			2	0.5	4.43E-04	EPB41, SPTBN1	spectrin-associated cytoskeleton [CC], spectrin [CC]
CG_ff_promoter_p_RM_18_7_1			1	0.5	8.12E-04	PCDHA13, PCDHA10	homophilic cell adhesion [BP]
CG_ff_promoter_p_RM_12_355_11			3	0.5	1.44E-04	TNFRSF11A	circadian temperature homeostasis [BP]
CG_ff_promoter_p_RM_12_393_7			2	0.5	2.68E-04	PTPRJ, RAC1, MDK	defecation [BP], cerebral cortex development [BP], ruffle membrane [CC]
CG_ff_promoter_p_RM_14_54_4			3	0.5	4.28E-04	SQRDL, KCNK3, GPD1L	open rectifier potassium channel activity [MF], glycerol-3-phosphate catabolic process [BP], negative regulation of protein kinase C signaling cascade [BP], sulfide:quinone oxidoreductase activity [MF]
CG_ff_promoter_p_RM_12_114_9			4	0.5	1.66E-04	RBBP8, GATA3, ONECUT3	transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_p_RM_12_277_11			2	0.5	2.39E-04	PRDX5, CTNNB1, ADNP2, MNAT1, DYNC2H1, PKD2	motile primary cilium [CC], regulation of cyclin-dependent protein kinase activity [BP], cellular response to reactive oxygen species [BP], cellular response to oxidative stress [BP], regulation of calcium ion import [BP]
CG_ff_promoter_p_RM_14_29_11			8	1.0	3.67E-04	KHK, FOXP4, FOS, E2F5	ketohexokinase activity [MF], transcription factor binding [MF]
CG_ff_promoter_p_RM_12_87_12			4	1.0	1.85E-04	INPPL1, ABI2, HCN2, KCNK2, CNTNAP1, KAT8	myeloid cell differentiation [BP], voltage-gated potassium channel complex [CC], SH3 domain binding [MF]
CG_ff_promoter_p_RM_12_391_4			1	0.5	2.34E-04	CTNS, CCKBR	gastrin receptor activity [MF], compound eye corneal lens development [BP], cholecystokinin receptor activity [MF], type B gastrin/cholecystokinin receptor binding [MF]
CG_ff_promoter_p_RM_12_93_10			2	0.5	2.92E-04	WDR62	neurogenesis [BP]
CG_ff_promoter_p_RM_14_74_6			2	0.5	3.52E-04	SLC5A2, B3GALT6, SIVA1, CCDC64, TGFBR2	positive regulation of tolerance induction to self antigen [BP], bronchus morphogenesis [BP], type III transforming growth factor beta receptor binding [MF], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF], CD27 receptor binding [MF], embryonic cranial skeleton morphogenesis [BP], Golgi to secretory granule transport [BP], low-affinity glucose:sodium symporter activity [MF]
CG_ff_promoter_p_RM_12_161_10			2	0.5	3.81E-04	STUB1, VPS13A, TRIB1, HSPB1, SDHA	negative regulation of protein kinase activity [BP], positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP], nervous system development [BP]
CG_ff_promoter_p_RM_12_159_15			2	0.5	3.47E-04	AP2M1, ARIH2, WNT3A	clathrin coat of coated pit [CC], hematopoietic stem cell proliferation [BP]
CG_ff_promoter_p_RM_12_130_13			2	0.5	2.50E-04	ZNF326, CEBPB, CAMSAP3, PPP4C, ALOX5, KIAA1967	RNA polymerase II core binding [MF], nuclear matrix [CC], DBIRD complex [CC], microtubule cytoskeleton organization [BP], regulation of microtubule cytoskeleton organization [BP]
CG_ff_promoter_p_RM_12_397_7			1	0.5	3.16E-04	NUDT1, MOCS3	URM1 activating enzyme activity [MF], enzyme active site formation via L-cysteine persulfide [BP], ATP diphosphatase activity [MF]
CG_ff_promoter_p_RM_18_15_2			1	0.5	5.47E-04	SOX11	positive regulation of lens epithelial cell proliferation [BP], closure of optic fissure [BP], neuroepithelial cell differentiation [BP], positive regulation of hippo signaling cascade [BP]
CG_ff_promoter_p_RM_12_49_6			2	1.0	4.02E-05	SLC39A13, MICA, ST6GAL1, HTR6	integral to Golgi membrane [CC], natural killer cell lectin-like receptor binding [MF], stimulatory C-type lectin receptor signaling pathway [BP], negative regulation of acetylcholine secretion [BP], beta-galactoside alpha-2,6-sialyltransferase activity [MF], negative regulation of gamma-aminobutyric acid secretion [BP]
CG_ff_promoter_p_RM_12_216_7			1	0.5	2.82E-04	SRC, SLC12A5	cellular response to progesterone stimulus [BP], thermosensory behavior [BP]
CG_ff_promoter_p_RM_12_254_9			1	0.5	1.88E-04	MALSU1, ITPA	negative regulation of mitochondrial translation [BP], ITP catabolic process [BP]
CG_ff_promoter_p_RM_12_388_9			2	0.5	2.37E-04	EPAS1, ARF6, CUX1, FGF18, FPGS, PALM, PACS2, WNT3A	protein targeting to plasma membrane [BP], filopodium membrane [CC], cellular protein localization [BP], regulation of dendritic spine development [BP], liver development [BP], lung development [BP]
CG_ff_promoter_p_RM_12_214_4			1	0.5	3.63E-04	SLC5A2, GATA6	negative regulation of transforming growth factor beta2 production [BP], low-affinity glucose:sodium symporter activity [MF]
CG_ff_promoter_p_RM_12_418_4			2	0.5	2.06E-04	DRD5, PDE1B	reactive oxygen species metabolic process [BP], response to amphetamine [BP]
CG_ff_promoter_p_RM_14_76_5			3	0.5	4.75E-04	PRDM16, TCF7, DMBX1, SOX11, SOX12, PKNOX2, POU3F3	central nervous system development [BP], sequence-specific DNA binding [MF], embryonic digestive tract morphogenesis [BP], RNA polymerase II transcription coactivator activity [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_p_RM_12_227_12			2	0.5	3.86E-04	IL15, SOX9	male germ-line sex determination [BP], intrahepatic bile duct development [BP], regulation of cell proliferation involved in tissue homeostasis [BP], extrathymic T cell selection [BP], retinal rod cell differentiation [BP], epithelial cell proliferation involved in prostatic bud elongation [BP], chondrocyte hypertrophy [BP]
CG_ff_promoter_p_RM_12_123_18			5	0.5	3.42E-04	KLF2, MAP2K5, RIPK2	nucleotide-binding oligomerization domain containing 2 signaling pathway [BP], nucleotide-binding oligomerization domain containing 1 signaling pathway [BP], cellular response to laminar fluid shear stress [BP]
CG_ff_promoter_p_RM_12_212_5			1	0.5	4.07E-04	TGFBR2	positive regulation of tolerance induction to self antigen [BP], bronchus morphogenesis [BP], type III transforming growth factor beta receptor binding [MF]
CG_ff_promoter_p_RM_12_291_7			2	0.5	3.12E-04	CDKN2C, IGF1R, PLD2, ADORA2A, PPARD, LHX9, ILK, SPRED3, ZHX2, VENTX, POU4F3, SLIT2, PGS1, CABLES1, TNFAIP2, PRDM8, SPTBN1, HOXD11, NAA16	axonogenesis [BP], negative regulation of smooth muscle cell migration [BP], corticospinal tract morphogenesis [BP], sequence-specific DNA binding [MF], negative regulation of vascular permeability [BP], negative regulation of protein phosphorylation [BP], negative regulation of phosphorylation [BP], neuron projection morphogenesis [BP], phosphatidylglycerol biosynthetic process [BP], axolemma [CC], N-terminal protein amino acid acetylation [BP], multicellular organismal development [BP], cell differentiation [BP], nervous system development [BP]
CG_ff_promoter_p_RM_12_247_19			3	0.5	2.52E-04	ABCG1, PSEN2, SMAD4	regulation of binding [BP], amyloid precursor protein catabolic process [BP]
CG_ff_promoter_p_RM_14_58_3			1	0.5	2.94E-04	MAP2K1, ANLN, IKZF1, SLC5A3	positive regulation of neutrophil differentiation [BP], myo-inositol:sodium symporter activity [MF], septin ring assembly [BP], receptor signaling protein tyrosine phosphatase activity [MF]
CG_ff_promoter_p_RM_12_137_12			2	1.0	1.11E-04	AQP6	nitrate transmembrane transporter activity [MF]
CG_ff_promoter_p_RM_12_210_9			2	0.5	4.26E-04	SGPL1	sphinganine-1-phosphate aldolase activity [MF]
CG_ff_promoter_p_RM_12_73_5			1	0.5	1.67E-04	MYB, GATA4	lung lobe formation [BP], embryonic digestive tract development [BP]
CG_ff_promoter_p_RM_12_249_19			2	0.5	2.17E-04	TRAF5, PNRC2, SCAMP1, STUB1, DNAJB2, DNAJC6, CSRP2BP, KHDRBS1, RAP1B, UBE2D1, KLHL2, MME, RNF4, RNF182, IL4R, FGF21	protein binding [MF], protein binding, bridging [MF], ubiquitin-protein ligase activity [MF], proteasomal ubiquitin-dependent protein catabolic process [BP], protein K63-linked ubiquitination [BP], Hsp70 protein binding [MF], heat shock protein binding [MF]
CG_ff_promoter_p_RM_16_12_1			1	0.5	3.01E-04	MLL5, GNAS, SLC12A5	multicellular organism growth [BP], mu-type opioid receptor binding [MF], thermosensory behavior [BP], post-embryonic body morphogenesis [BP], DNA methylation [BP]
CG_ff_promoter_p_RM_12_111_9			5	0.5	1.99E-04	ADAMTSL4, VWC2	interstitial matrix [CC]
CG_ff_promoter_p_RM_12_204_12			3	0.5	4.24E-04	NIT2, GATA4, PHACTR2, PPP1R37	protein phosphatase inhibitor activity [MF], lung lobe formation [BP], omega-amidase activity [MF]
CG_ff_promoter_p_RM_14_53_2			2	0.5	4.45E-04	TDRD7, PIAS3	protein N-terminus binding [MF]
CG_ff_promoter_p_RM_16_14_1			1	0.5	7.34E-04	PCDHB11, SPTBN4, PCDHB14, PCDHB12	axon hillock [CC], homophilic cell adhesion [BP], cell body fiber [CC], synapse assembly [BP], calcium ion binding [MF], calcium-dependent cell-cell adhesion [BP], transmission of nerve impulse [BP], nervous system development [BP]
CG_ff_promoter_p_RM_18_11_1			1	0.5	7.35E-04	PCDHGA8, PCDHGA4, PCDHGA7, PCDHGA12, PCDHGB3	homophilic cell adhesion [BP], calcium ion binding [MF]
CG_ff_promoter_p_RM_12_94_5			2	0.5	3.10E-04	RHOB, IST1	cell cycle cytokinesis [BP]
CG_ff_promoter_p_RM_12_172_9			4	0.5	3.00E-04	WNT1, GUCY1A3, ZNF703	regulation of transforming growth factor beta receptor signaling pathway [BP], guanylate cyclase complex, soluble [CC], response to defense-related host nitric oxide production [BP], negative regulation of cell-cell adhesion [BP], canonical Wnt receptor signaling pathway involved in negative regulation of apoptotic process [BP], central nervous system morphogenesis [BP], midbrain-hindbrain boundary maturation during brain development [BP], negative regulation of DNA damage checkpoint [BP], cerebellum formation [BP]
CG_ff_promoter_p_RM_18_13_1			2	0.5	3.09E-04	TRIM24	perichromatin fibrils [CC]
CG_ff_promoter_p_RM_12_260_21			2	0.5	4.44E-04	HEMK1, G6PC3, HK1	glucose 6-phosphate metabolic process [BP], N-methyltransferase activity [MF], protein methyltransferase activity [MF]
CG_ff_promoter_p_RM_12_34_12			1	0.5	7.40E-05	EXO1, TFAP2C	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], double-stranded DNA specific 5'-3' exodeoxyribonuclease activity [MF]
CG_ff_promoter_p_RM_12_124_16			2	0.5	2.37E-04	FZD3, HINFP, SGCA, FOXO3, UTRN, ZIC2, CTHRC1, MAPK8IP3, HSF1	neural tube closure [BP], dystrophin-associated glycoprotein complex [CC], embryonic placenta development [BP], neuron projection membrane [CC], inner ear receptor stereocilium organization [BP], in utero embryonic development [BP], embryo development [BP]
CG_ff_promoter_p_RM_14_13_9			4	0.5	5.68E-04	GREM1, CHD7, NR4A3, ID4, AGO4, AK7, ALMS1, SLIT2, HES1, TMEM57, ADCYAP1R1, GATA3, AGO3, SGPL1	ureteric bud development [BP], ureteric bud formation [BP], fat cell differentiation [BP], micro-ribonucleoprotein complex [CC], negative regulation of cellular response to growth factor stimulus [BP], kidney development [BP], telencephalon development [BP], brain development [BP], negative regulation of translation involved in gene silencing by miRNA [BP], negative regulation of oligodendrocyte differentiation [BP], semicircular canal morphogenesis [BP], regulation of fat cell differentiation [BP], metanephros development [BP], negative regulation of monocyte chemotaxis [BP], negative regulation of leukocyte chemotaxis [BP], negative regulation of gene expression [BP], development of primary female sexual characteristics [BP]
CG_ff_promoter_p_RM_12_350_10			3	0.5	1.62E-04	AGAP3, MMP17, PRSS41, MMP25	anchored to membrane [CC], protein import into nucleus, translocation [BP]
CG_ff_promoter_p_RM_14_106_2			2	0.5	4.91E-05	ALLC	allantoicase activity [MF], allantoin catabolic process [BP]
CG_ff_promoter_p_RM_12_411_6			3	0.5	2.89E-04	GLYCTK, VIL1, CST6, RGL1	Ral guanyl-nucleotide exchange factor activity [MF], glycerate kinase activity [MF], lysophosphatidic acid binding [MF], cysteine-type endopeptidase inhibitor activity [MF]
CG_ff_promoter_p_RM_12_150_8			2	0.5	2.15E-04	GCDH, RGN, TFAP2C	glutaryl-CoA dehydrogenase activity [MF], dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], gluconolactonase activity [MF]
CG_ff_promoter_p_RM_14_100_3			2	0.5	4.95E-04	MGAT2, TPM1, CMPK1	dUDP biosynthetic process [BP], UMP kinase activity [MF], alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], CDP biosynthetic process [BP], positive regulation of heart rate by epinephrine [BP], muscle thin filament tropomyosin [CC], dCDP biosynthetic process [BP], UDP biosynthetic process [BP]
CG_ff_promoter_p_RM_12_326_9			2	0.5	2.26E-04	RAC1, GPR98, NPW	negative regulation of interleukin-23 production [BP], embryonic olfactory bulb interneuron precursor migration [BP], engulfment of apoptotic cell [BP], neuropeptide signaling pathway [BP]
CG_ff_promoter_p_RM_12_298_4			3	0.5	2.84E-04	GNAS, GREM1	negative regulation of bone mineralization involved in bone maturation [BP], negative regulation of bone trabecula formation [BP], post-embryonic body morphogenesis [BP]
CG_ff_promoter_p_RM_16_16_2			3	0.5	3.53E-04	ACR	acrosome matrix dispersal [BP], amidase activity [MF]
CG_ff_promoter_p_RM_12_199_17			4	0.5	3.78E-04	BMPR1A, GDF7, HOXC5, HOXC4, MKL2, SNAPC2, FOXF1, ZNF274, FSCN2, YY1	anatomical structure morphogenesis [BP], lateral mesodermal cell differentiation [BP], lateral mesoderm development [BP], positive regulation of pathway-restricted SMAD protein phosphorylation [BP], sequence-specific DNA binding transcription factor activity [MF], anterior/posterior pattern specification [BP], pattern specification process [BP], transcription from RNA polymerase II promoter [BP], endocardial cushion development [BP], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_p_RM_14_15_4			2	0.5	1.19E-04	PCDHB14, RIPK1, PCDHB12, PCDHB16, MTO1, BGLAP	regulation of ATP:ADP antiporter activity [BP], homophilic cell adhesion [BP], calcium ion binding [MF], mitochondrial tRNA wobble uridine modification [BP], calcium-dependent cell-cell adhesion [BP], synapse assembly [BP]
CG_ff_promoter_p_RM_12_96_10			2	0.5	2.92E-04	GNAS, CANX	ionotropic glutamate receptor binding [MF]
CG_ff_promoter_p_RM_12_77_4			2	0.5	2.95E-04	ESPL1	mitotic sister chromatid segregation [BP]
CG_ff_promoter_p_RM_12_402_11			5	0.5	3.95E-04	CEBPB, TGFBR1, ERBB2IP, CHD1L, ZNF761, SOX12, FOXL1, UNCX, ILK, WRNIP1, CDKN2C, PIAS4, DRAP1, CDKN1B, ATP6V0E2, ATOH8, LZTS2, NR1D2, ZNF74, HIC1, ZBTB1	Wnt receptor signaling pathway [BP], establishment or maintenance of epithelial cell apical/basal polarity [BP], cell growth [BP], sequence-specific DNA binding [MF], regulation of apoptotic process [BP], cyclin-dependent protein kinase inhibitor activity [MF], DNA binding [MF]
CG_ff_promoter_p_RM_12_186_11			3	0.5	4.23E-04	D2HGDH, TCF7L1, ETV2	positive regulation of transcription from RNA polymerase II promoter during mitosis [BP], BMP signaling pathway involved in mesodermal cell fate specification [BP], (R)-2-hydroxyglutarate dehydrogenase activity [MF]
CG_ff_promoter_p_RM_12_38_10			2	0.5	1.03E-04	BTG2	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [BP]
CG_ff_promoter_p_RM_14_102_4			3	0.5	2.87E-04	TPX2, EPHB6, PKD2, SORCS3, ADRA2A, CCKBR	negative regulation of calcium ion transmembrane transporter activity [BP], activation of protein kinase activity [BP], type B gastrin/cholecystokinin receptor binding [MF], gastrin receptor activity [MF], metanephric cortex development [BP], phospholipase C-activating G-protein coupled receptor signaling pathway [BP], positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP], negative regulation of adrenergic receptor signaling pathway [BP], renal artery morphogenesis [BP], phospholipase C-activating adrenergic receptor signaling pathway [BP], calcium ion homeostasis [BP], metanephric cortical collecting duct development [BP], adenylate cyclase-inhibiting adrenergic receptor signaling pathway [BP], neuropeptide receptor activity [MF]
CG_ff_promoter_p_RM_12_152_7			1	0.5	1.75E-04	IRGC, F2RL1	symbiont-containing vacuole membrane [CC], positive regulation of eosinophil degranulation [BP], defense response to Gram-negative bacterium [BP], positive regulation of renin secretion into blood stream [BP], chemokine (C-C motif) ligand 2 secretion [BP], positive regulation of neutrophil mediated killing of gram-negative bacterium [BP], negative regulation of chemokine secretion [BP]
CG_ff_promoter_p_RM_12_118_21			2	0.5	3.20E-04	FOXK1, LAPTM4B, NCS1, GTF3C4, HIC1, DAO, POLD1, CBFB, UNC50, NPR1, ACVR2B, NOS3, TRAF4, NLGN3, WIPI2, LMX1B, CSNK1G2, P2RY1, FLNB, CUL4A, NPW, FOXC1, SNX25, AMOTL1	muscle organ development [BP], protein binding [MF], lymphangiogenesis [BP], cell surface receptor signaling pathway [BP], regulation of blood vessel size [BP], blood vessel remodeling [BP], signal transduction [BP], cell communication [BP], multicellular organismal development [BP], regulation of vasodilation [BP]
CG_ff_promoter_p_RM_14_75_3			3	0.5	3.39E-04	SPATA18, SYK	mitochondrion degradation by induced vacuole formation [BP], cellular response to molecule of fungal origin [BP]
CG_ff_promoter_p_RM_12_400_20			3	0.5	2.78E-04	BMPER, GDF7	regulation of pathway-restricted SMAD protein phosphorylation [BP], pathway-restricted SMAD protein phosphorylation [BP], activin receptor signaling pathway [BP]
CG_ff_promoter_p_RM_18_6_2			1	0.5	3.32E-04	CHRNB3, PCDHB4, PCDHB13, PCDHB11, PCDHB14, PCDHB8	synaptic transmission [BP], cell adhesion [BP], homophilic cell adhesion [BP], calcium ion binding [MF], calcium-dependent cell-cell adhesion [BP], synapse assembly [BP]
CG_ff_promoter_p_RM_12_385_11			2	0.5	3.52E-04	BCL2L11, LMO4, SMO, C1GALT1, FOXF2, INSIG1, RNF139, PRDM16	kidney development [BP], negative regulation of protein complex assembly [BP], regulation of ER to Golgi vesicle-mediated transport [BP], renal system development [BP], palate development [BP]
CG_ff_promoter_p_RM_12_179_11			2	0.5	3.33E-04	IRAK3, SMAD6, CAV1, MMP14	response to estrogen stimulus [BP], tissue remodeling [BP], negative regulation of cytokine-mediated signaling pathway [BP]
CG_ff_promoter_p_RM_12_406_10			2	0.5	7.36E-05	NAA60	N-terminal peptidyl-methionine acetylation [BP]
CG_ff_promoter_p_RM_14_109_4			2	0.5	3.14E-04	POR, KCNIP3, FOXC1, ADRA2C, ADRB1	regulation of blood vessel size [BP], nitrate catabolic process [BP], sensory perception of pain [BP], positive regulation of cell growth involved in cardiac muscle cell development [BP], epinephrine binding [MF], positive regulation of the force of heart contraction by norepinephrine [BP], nitric oxide catabolic process [BP], alpha-2A adrenergic receptor binding [MF], negative regulation of smooth muscle contraction [BP]
CG_ff_promoter_p_RM_12_262_11			4	0.5	3.28E-04	VAX2, ZIC2	chromatin DNA binding [MF]
CG_ff_promoter_p_RM_12_387_13			3	0.5	2.16E-04	RBBP8, BMP2, SOX11, PSEN1, DSCR6, BACE2	negative regulation of transcription from RNA polymerase II promoter [BP], aspartic-type endopeptidase activity [MF], negative regulation of transcription, DNA-dependent [BP]
CG_ff_promoter_p_RM_18_8_2			1	0.5	6.86E-05	ENTPD6	guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [MF]
CG_ff_promoter_p_RM_12_269_16			3	0.5	1.87E-04	PHF15, KAT8	histone H4-K8 acetylation [BP], histone H4-K5 acetylation [BP]
CG_ff_promoter_p_RM_12_65_10			2	0.5	3.75E-05	IRGM	autophagy [BP]
CG_ff_promoter_p_RM_14_32_10			1	0.5	2.67E-04	CYR61, PRKCE	TRAM-dependent toll-like receptor 4 signaling pathway [BP], positive regulation of phospholipase activity [BP], positive regulation of cellular glucuronidation [BP], intussusceptive angiogenesis [BP], positive regulation of cell-substrate adhesion [BP]
CG_ff_promoter_p_RM_12_252_20			2	0.5	3.14E-04	PTK2B	positive regulation of cell-matrix adhesion [BP]
CG_ff_promoter_p_RM_14_71_2			2	0.5	5.35E-04	ENOPH1, FZR1, STUB1	DNA repair [BP], acireductone synthase activity [MF]
CG_ff_promoter_p_RM_12_184_15			4	0.5	2.34E-04	APLP1, ANLN, PVRL2, ATP2A2, HTR6	septin ring assembly [BP], cellular response to norepinephrine stimulus [BP], G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [BP], negative regulation of acetylcholine secretion [BP], virion attachment, binding of host cell surface coreceptor [BP], negative regulation of gamma-aminobutyric acid secretion [BP], calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF], alpha-2B adrenergic receptor binding [MF]
CG_ff_promoter_p_RM_14_73_4			2	0.5	3.05E-04	TGFBR1, CDKN1B, H6PD, SSTR5, MNAT1, GNAI2, CUL1, MMP15	response to alcohol [BP], S phase of mitotic cell cycle [BP], SMAD binding [MF], G1/S transition of mitotic cell cycle [BP], activation of MAPKK activity [BP], positive regulation of catalytic activity [BP], G1 phase of mitotic cell cycle [BP], negative regulation of cell proliferation [BP], glucose 1-dehydrogenase [NAD(P)] activity [MF]
CG_ff_promoter_p_RM_12_128_7			4	0.5	3.93E-04	CHAMP1, BUB1B, SMAD4, PNP, TCHP, PCNT, BRCA2	centrosome [CC], cytoskeleton [CC], microtubule organizing center [CC], protein localization to kinetochore [BP]
CG_ff_promoter_p_RM_18_4_1			1	0.5	1.03E-04	IL17RA	interleukin-17 receptor activity [MF]
CG_ff_promoter_p_RM_20_8_2			1	0.5	7.59E-05	L3MBTL1, SLC5A5, HTR3C, SLC15A2	SAM domain binding [MF], sodium:iodide symporter activity [MF], iodide transport [BP], nucleosomal histone binding [MF], peptide:hydrogen symporter activity [MF], high affinity oligopeptide transporter activity [MF], dipeptide transporter activity [MF], transmembrane transport [BP], iodide transmembrane transporter activity [MF]
CG_ff_promoter_p_RM_16_11_2			2	0.5	2.88E-04	WFS1, POLD1	DNA replication proofreading [BP], negative regulation of type B pancreatic cell apoptotic process [BP], polyubiquitinated misfolded protein transport [BP]
CG_ff_promoter_p_RM_14_57_4			2	1.0	1.34E-04	RHOQ, FAM20C, NT5M, ADHFE1, CCKBR	hydroxyacid-oxoacid transhydrogenase activity [MF], GBD domain binding [MF], gastrin receptor activity [MF], dUMP catabolic process [BP], dentinogenesis [BP], type B gastrin/cholecystokinin receptor binding [MF], osteoclast maturation [BP]
CG_ff_promoter_p_RM_12_202_26			2	0.5	3.77E-04	ISL1, MAP3K10	bHLH transcription factor binding [MF]
CG_ff_promoter_p_RM_20_6_1			1	0.5	1.21E-04	PRKCG, MED25	positive regulation of chromatin binding [BP], positive regulation of mismatch repair [BP], positive regulation of mediator complex assembly [BP], calcium-dependent protein kinase C activity [MF]
CG_ff_promoter_p_RM_20_14_2			2	1.0	9.29E-05	PCCB	propionyl-CoA carboxylase activity [MF]
CG_ff_promoter_p_RM_14_78_2			2	0.5	4.32E-04	SLC25A26, ADPRHL2, UTP20, DKK1, LARS2	endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], S-adenosyl-L-methionine transport [BP], positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway [BP], endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], leucine-tRNA ligase activity [MF], leucyl-tRNA aminoacylation [BP], mitochondrial matrix [CC], S-adenosyl-L-methionine transmembrane transporter activity [MF], negative regulation of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment [BP], poly(ADP-ribose) glycohydrolase activity [MF], negative regulation of cardiac muscle cell differentiation [BP]
CG_ff_promoter_p_RM_12_116_11			4	0.5	1.67E-04	ABCG1, SMAD4	transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [MF], sterol-transporting ATPase activity [MF], detection of hormone stimulus [BP]
CG_ff_promoter_p_RM_12_92_9			2	0.5	2.45E-04	RNASEH2B, RNASEH2A	ribonuclease H2 complex [CC]
CG_ff_promoter_p_RM_20_10_3			1	0.5	9.77E-04	PCDHA13, PCDHA6, PCDHA7, PCDHA5, PCDHA10	homophilic cell adhesion [BP], nervous system development [BP], integral to plasma membrane [CC], calcium ion binding [MF], cell adhesion [BP]
CG_ff_promoter_p_RM_12_11_6			2	1.0	1.79E-04	PTEN, GSX1, WNT3A	phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [MF], negative regulation of axonogenesis [BP], inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [MF], spinal cord association neuron differentiation [BP]
CG_ff_promoter_p_RM_18_14_8			1	0.5	5.67E-04	PRMT8, GNAS, GRIK2, JARID2, ADRB1, SETD1B, MLL5, EHMT1	chromatin modification [BP], histone methylation [BP], regulation of inhibitory postsynaptic membrane potential [BP], methyltransferase activity [MF], histone methyltransferase complex [CC], histone methyltransferase activity (H3-K4 specific) [MF], histone-lysine N-methyltransferase activity [MF], protein-lysine N-methyltransferase activity [MF], DNA methylation [BP], S-adenosylmethionine-dependent methyltransferase activity [MF]
CG_ff_promoter_p_RM_12_373_12			4	0.5	3.10E-04	WNT5B, OVCA2, EMX1, SOX11, WNT3A	convergent extension [BP], response to retinoic acid [BP], neuron differentiation [BP], frizzled-2 binding [MF], Wnt receptor signaling pathway, calcium modulating pathway [BP]
CG_ff_promoter_p_RM_18_2_2			1	0.5	3.24E-04	PCDHGA8, PCDHGB6, PCDHGA12, PCDHGA7, PCDHGB3	homophilic cell adhesion [BP], calcium ion binding [MF]
CG_ff_promoter_p_RM_12_163_24			2	0.5	3.41E-04	ARSG, BNIP3L, PRKCE, TMEM50A, HPS6, ATP11B, ATP1A1, HTRA2, ADORA2A	endoplasmic reticulum [CC], positive regulation of synaptic transmission, GABAergic [BP]
CG_ff_promoter_p_RM_12_396_13			3	0.5	3.75E-04	OGDH, CRCP	DNA polymerase III complex [CC], oxoglutarate dehydrogenase (NAD+) activity [MF]
CG_ff_promoter_p_RM_12_108_19			4	0.5	2.73E-04	ACSF3, FXYD5	malonate catabolic process [BP], malonyl-CoA synthetase activity [MF], negative regulation of calcium-dependent cell-cell adhesion [BP]
CG_ff_promoter_p_RM_12_217_6			2	0.5	2.60E-04	IFRD1, DAND5, HIF1AN	sequestering of nodal from receptor via nodal binding [BP], peptidyl-histidine hydroxylation [BP], peptidyl-histidine dioxygenase activity [MF], peptidyl-asparagine 3-dioxygenase activity [MF], peptidyl-asparagine hydroxylation [BP], adult somatic muscle development [BP]
CG_ff_promoter_p_RM_12_99_5			2	1.0	2.16E-04	RBBP8	blastocyst hatching [BP], DNA double-strand break processing involved in repair via single-strand annealing [BP]
CG_ff_promoter_p_RM_12_381_11			3	0.5	3.05E-04	NTRK2, FMN2, ADD3	regulation of neurotransmitter secretion [BP], cell cortex [CC]
CG_ff_promoter_p_RM_20_16_2			1	0.5	6.90E-04	PCDHA11, PCDHA13, PCDHA7, PCDHA5, PCDHA10	homophilic cell adhesion [BP], nervous system development [BP], integral to plasma membrane [CC], calcium ion binding [MF], cell adhesion [BP]
CG_ff_promoter_p_RM_12_250_16			2	0.5	5.44E-04	GCDH	glutaryl-CoA dehydrogenase activity [MF]
CG_ff_promoter_p_RM_12_340_4			2	0.5	4.05E-04	MAP2K4, TSSK3	protein serine/threonine kinase activity [MF]
CG_ff_promoter_p_RM_20_2_1			1	0.5	3.53E-04	GPIHBP1	positive regulation of chylomicron remnant clearance [BP], chylomicron binding [MF], lipase binding [MF]
CG_ff_promoter_p_RM_12_273_20			2	0.5	2.88E-04	HINFP, RCC1	histone binding [MF]
CG_ff_promoter_p_RM_14_43_10			3	0.5	3.32E-04	FOXL1	visceral mesoderm-endoderm interaction involved in midgut development [BP]
CG_ff_promoter_p_RM_20_18_2			1	0.5	6.39E-04	PCDHA6, PCDHA4, PCDHA5, HIST1H2AH, PCDHA10, HIST1H2BO, HIST1H2AC, PCDHA13	homophilic cell adhesion [BP], cell adhesion [BP], nucleosome assembly [BP], protein heterodimerization activity [MF], calcium ion binding [MF], nucleosome [CC]
CG_ff_promoter_p_RM_18_10_2			1	0.5	3.37E-04	PCDHGA12, AGPAT6, PCDHGA8, PCDHGA4, PCDHGA5, PCDHGA11	homophilic cell adhesion [BP], calcium ion binding [MF], glandular epithelial cell maturation [BP]
CG_ff_promoter_p_RM_12_135_14			2	0.5	2.02E-04	MTHFD2L, PDX1	organ senescence [BP], histidine biosynthetic process [BP], methylenetetrahydrofolate dehydrogenase (NAD+) activity [MF], response to chlorate [BP]
CG_ff_promoter_p_RM_14_98_10			4	0.5	2.81E-04	GTF2IRD1, TLE4, NFATC1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_ff_promoter_p_RM_12_346_7			2	0.5	2.00E-04	UROD	uroporphyrinogen decarboxylase activity [MF]
CG_ff_promoter_p_RM_12_36_16			2	1.0	4.07E-05	CDH13, FUT8, SPR	N-glycan fucosylation [BP], adiponectin binding [MF], sepiapterin reductase activity [MF], glycoprotein 6-alpha-L-fucosyltransferase activity [MF]
CG_ff_promoter_p_RM_12_284_13			3	0.5	2.78E-04	TAF5, HHEX, WNT10A, MLLT10, SMO, PAX2, SOX11, ARID3A	mesenchymal to epithelial transition involved in metanephros morphogenesis [BP], forebrain morphogenesis [BP], positive regulation of epithelial cell proliferation [BP], embryonic digestive tract morphogenesis [BP], brain morphogenesis [BP], regulation of stem cell maintenance [BP], hair follicle morphogenesis [BP], neural crest cell differentiation [BP], optic cup morphogenesis involved in camera-type eye development [BP], embryonic camera-type eye development [BP], pancreas development [BP], positive regulation of transcription from RNA polymerase II promoter [BP], transcription regulatory region DNA binding [MF], mesenchymal to epithelial transition [BP], camera-type eye development [BP], axis specification [BP], positive regulation of branching involved in ureteric bud morphogenesis [BP]
CG_ff_promoter_p_RM_18_16_1			1	0.5	7.93E-04	PCDHB15, PCDHB14, PCDHB13	homophilic cell adhesion [BP], calcium-dependent cell-cell adhesion [BP], calcium ion binding [MF], synapse assembly [BP], cell adhesion [BP]
CG_ff_promoter_p_RM_16_15_1			3	0.5	4.97E-04	EGR1, NR2F2, VIL1	cytoplasmic actin-based contraction involved in cell motility [BP], lysophosphatidic acid binding [MF], radial pattern formation [BP], response to norepinephrine stimulus [BP], regulation of transcription involved in lymphatic endothelial cell fate commitment [BP], positive regulation of glomerular metanephric mesangial cell proliferation [BP], cellular response to mycophenolic acid [BP], cellular response to isoquinoline alkaloid [BP], regulation of lamellipodium morphogenesis [BP]
CG_ff_promoter_p_RM_12_107_16			2	0.5	2.59E-04	MYOD1, MYC	E-box binding [MF]
CG_ff_promoter_p_RM_12_348_5			1	0.5	1.39E-04	SWSAP1, OPRL1, PDX1	organ senescence [BP], nociceptin receptor activity [MF], Shu complex [CC], response to chlorate [BP]
CG_ff_promoter_p_RM_12_327_8			3	0.5	2.70E-04	HEXB, LZTR1, KLHL17, SYK	anatomical structure morphogenesis [BP], male courtship behavior [BP], cellular response to molecule of fungal origin [BP], POZ domain binding [MF], protein complex scaffold [MF]
CG_ff_promoter_p_RM_18_12_7			2	0.5	5.73E-04	CHD7, NR4A3	semicircular canal morphogenesis [BP]
CG_ff_promoter_p_RM_12_54_15			2	0.5	2.66E-04	LSM11, CYP46A1	U7 snRNA binding [MF], cholesterol 24-hydroxylase activity [MF]
CG_ff_promoter_p_RM_14_94_2			2	0.5	3.98E-04	BIRC3, SLC25A37	negative regulation of necroptosis [BP], mitochondrial iron ion transport [BP]
CG_ff_promoter_p_RM_12_121_5			3	0.5	1.53E-04	CARM1, GTPBP4	negative regulation of collagen binding [BP], negative regulation of protein binding [BP], histone H3-R17 methylation [BP], histone methyltransferase activity (H3-R17 specific) [MF]
CG_ff_promoter_p_RM_12_45_13			1	0.5	2.32E-04	FOXL1	visceral mesoderm-endoderm interaction involved in midgut development [BP]
CG_ff_promoter_p_RM_12_366_28			3	0.5	3.98E-04	AK4	AMP metabolic process [BP]
CG_ff_promoter_p_RM_14_50_4			1	0.5	2.42E-04	SLC16A3, CDS2, SRR	D-serine biosynthetic process [BP], D-serine ammonia-lyase activity [MF], threonine racemase activity [MF], D-serine metabolic process [BP], pyruvate metabolic process [BP], serine racemase activity [MF], phosphatidate cytidylyltransferase activity [MF]
CG_ff_promoter_p_RM_14_56_2			3	0.5	3.95E-04	GCDH	glutaryl-CoA dehydrogenase activity [MF]
CG_ff_promoter_p_RM_12_368_9			4	0.5	7.27E-05	BUB3, CTCF, ANLN	regulation of molecular function, epigenetic [BP], regulation of chromosome segregation [BP], chromatin insulator sequence binding [MF], septin ring assembly [BP]
CG_ff_promoter_p_RM_14_96_3			2	0.5	2.29E-04	CYR61, ICT1	mitochondrial translational termination [BP], translation release factor activity, codon nonspecific [MF], intussusceptive angiogenesis [BP]
CG_ff_promoter_p_RM_12_405_8			2	0.5	3.60E-04	NT5E, ENTPD6	guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [MF], adenosine biosynthetic process [BP]
CG_ff_promoter_p_RM_12_6_33			5	1.0	6.90E-05	SLCO2B1, SLCO3A1	sodium-independent organic anion transport [BP]
CG_ff_promoter_p_RM_12_310_14			2	0.5	2.02E-04	PPARGC1B	AF-2 domain binding [MF]
CG_ff_promoter_p_RM_12_56_10			2	1.0	8.07E-05	CHEK1, CROT	carnitine O-octanoyltransferase activity [MF], regulation of histone H3-K9 acetylation [BP], regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [BP], histone H3-T11 phosphorylation [BP], histone kinase activity (H3-T11 specific) [MF]
CG_ff_promoter_p_RM_12_236_21			2	0.5	3.23E-04	RB1, TPM1, GRIN1	striated muscle cell differentiation [BP], positive regulation of heart rate by epinephrine [BP], propylene metabolic process [BP]
CG_ff_promoter_p_RM_12_164_6			2	0.5	2.62E-04	TTLL3, CRTAP, FPGS	peptidyl-proline hydroxylation to 3-hydroxy-L-proline [BP], tetrahydrofolylpolyglutamate synthase activity [MF], protein-glycine ligase activity, initiating [MF], protein polyglycylation [BP], protein-glycine ligase activity [MF]
CG_ff_promoter_p_RM_12_282_8			3	0.5	3.27E-04	RQCD1, CNOT11	nuclear-transcribed mRNA poly(A) tail shortening [BP]
CG_ff_promoter_p_RM_12_218_10			2	0.5	5.06E-04	HIF1AN, VHL	regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP], negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP]
CG_ff_promoter_p_RM_12_271_14			2	0.5	3.72E-04	HOOK3, KLF2, MAP2K5, SOX2	cellular response to laminar fluid shear stress [BP], neuronal stem cell maintenance [BP]
CG_ff_promoter_p_RM_12_362_7			3	0.5	2.02E-04	HLA-F, HLA-A	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [BP], MHC class I protein complex [CC], integral to lumenal side of endoplasmic reticulum membrane [CC], MHC class I receptor activity [MF]
CG_ff_promoter_p_RM_16_18_1			1	0.5	2.62E-04	NOS3	negative regulation of muscle hyperplasia [BP], nitric-oxide synthase activity [MF], smooth muscle hyperplasia [BP]
CG_ff_promoter_p_RM_12_68_5			1	0.5	3.88E-04	NADSYN1, ASNA1	detoxification of arsenic-containing substance [BP], NAD+ synthase (glutamine-hydrolyzing) activity [MF]
CG_ff_promoter_p_RM_12_286_9			2	0.5	3.25E-04	RGL1	Ral guanyl-nucleotide exchange factor activity [MF]
CG_ff_promoter_p_RM_12_301_7			2	0.5	2.97E-04	PARK7, CLIC4, FOSB, SPHK1	positive regulation of oxidative phosphorylation uncoupler activity [BP], cellular response to calcium ion [BP], sphingoid catabolic process [BP]
CG_ff_promoter_p_RM_12_297_6			3	0.5	2.17E-04	SMARCB1, GATA3, TBX1	ear development [BP], pro-T cell differentiation [BP], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], otic vesicle development [BP], coronary artery morphogenesis [BP], pharyngeal system development [BP], ear morphogenesis [BP], vagus nerve morphogenesis [BP], parathyroid gland development [BP], interleukin-4 secretion [BP], positive regulation of interleukin-13 secretion [BP], negative regulation of cell proliferation involved in mesonephros development [BP], positive regulation of tongue muscle cell differentiation [BP], cellular response to fibroblast growth factor stimulus [BP], positive regulation of secondary heart field cardioblast proliferation [BP], positive regulation of interleukin-5 production [BP], thymus development [BP], positive regulation of transcription, DNA-dependent [BP], blastocyst hatching [BP], heart morphogenesis [BP], ureter maturation [BP], positive regulation of transcription from RNA polymerase II promoter [BP], positive regulation of thyroid hormone generation [BP], regulation of transcription from RNA polymerase II promoter [BP], parathyroid hormone secretion [BP], negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], positive regulation of ureteric bud formation [BP], regulation of cellular response to X-ray [BP], inner ear morphogenesis [BP], type IV hypersensitivity [BP], positive regulation of interleukin-5 secretion [BP], regulation of histone H3-K27 methylation [BP], canonical Wnt receptor signaling pathway involved in metanephric kidney development [BP], regulation of organ morphogenesis [BP], transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_p_RM_12_244_12			2	0.5	3.77E-04	MPP5	establishment of protein localization to plasma membrane [BP]
CG_ff_promoter_p_RM_12_231_11			1	0.5	1.03E-04	TRAF2, STUB1	protein autoubiquitination [BP], protein K63-linked ubiquitination [BP]
CG_ff_promoter_p_RM_12_354_10			4	0.5	2.14E-04	GATA4, VASH2, AGGF1	positive regulation of angiogenesis [BP]
CG_ff_promoter_p_RM_12_129_11			2	0.5	3.47E-04	VIM, CA2	Bergmann glial cell differentiation [BP], positive regulation of cellular pH reduction [BP]
CG_ff_promoter_p_RM_12_280_10			3	0.5	2.70E-04	E2F4, LIME1, IFITM2, ROBO3, BTRC, MED25, RXRA, SOX9, SMARCA2, PRPF6, FOXG1, CAV1, KDM1A	negative regulation of transcription, DNA-dependent [BP], positive regulation of transcription from RNA polymerase II promoter [BP], regulation of transcription from RNA polymerase II promoter [BP], mammary gland development [BP], axon midline choice point recognition [BP], response to interferon-beta [BP]
CG_ff_promoter_p_RM_12_120_16			4	0.5	3.04E-04	BICD1	regulation of proteinase activated receptor activity [BP], negative regulation of phospholipase C activity [BP], proteinase activated receptor binding [MF], negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP], host cell viral assembly compartment [CC]
CG_ff_promoter_p_RM_12_289_10			2	0.5	2.35E-04	DACT1, NOG, PRKCE, CHRD, RGMB, TSC2, BCL2L11	negative regulation of BMP signaling pathway [BP], tube formation [BP], negative regulation of osteoblast differentiation [BP], BMP signaling pathway [BP], fibroblast growth factor receptor signaling pathway [BP], 14-3-3 protein binding [MF], negative regulation of Wnt receptor signaling pathway [BP], gastrulation with mouth forming second [BP]
CG_ff_promoter_p_RM_12_166_7			2	0.5	2.15E-04	ADRA2C, MT3	activation of protein kinase B activity [BP]
CG_ff_promoter_p_RM_12_364_12			2	0.5	3.40E-04	CDK5R1, LCK, CHAT, GRM7	cellular zinc ion homeostasis [BP], axon [CC]
CG_ff_promoter_p_RM_20_9_3			1	0.5	6.28E-04	PCDHA13, PCDHA6, PCDHA4, PCDHA9, PCDHA10	homophilic cell adhesion [BP], calcium ion binding [MF], cell adhesion [BP]
CG_ff_promoter_p_RM_12_409_6			3	0.5	2.23E-04	PRSS41, CHD7, HTRA2, PSD4, PRSS38	serine-type endopeptidase activity [MF], neuron differentiation [BP], adult walking behavior [BP]
CG_ff_promoter_p_RM_12_193_12			4	0.5	3.19E-04	PPP2R4, SMPD1	positive regulation of protein dephosphorylation [BP]
CG_ff_promoter_p_RM_12_187_6			3	0.5	2.29E-04	TREX1, LHX4, RNASEH2A, POLD3, CDT1	DNA replication [BP], mismatch repair [BP], placenta development [BP]
CG_ff_promoter_p_RM_12_62_4			1	0.5	1.21E-04	VIL1, TSC2, F2R, NTMT1, REM1	cytoplasmic actin-based contraction involved in cell motility [BP], lysophosphatidic acid binding [MF], N-terminal peptidyl-proline dimethylation [BP], N-terminal peptidyl-serine dimethylation [BP], N-terminal peptidyl-alanine trimethylation [BP], small GTPase mediated signal transduction [BP], negative regulation of renin secretion into blood stream [BP], caveola [CC], N-terminal peptidyl-serine trimethylation [BP]
CG_ff_promoter_p_RM_12_148_7			3	0.5	1.87E-04	TNFSF11, ZAK, ADRA2A, MDFI	activation of protein kinase activity [BP], activation of JUN kinase activity [BP], positive regulation of MAP kinase activity [BP]
CG_ff_promoter_p_RM_20_17_3			2	1.0	2.29E-04	SLC3A2	leucine import [BP], tryptophan transport [BP]
CG_ff_promoter_p_RM_12_307_10			1	0.5	1.72E-04	RYR2, REST, PAX2, KCNK4	calcium channel complex [CC], negative regulation of amniotic stem cell differentiation [BP], vestibulocochlear nerve formation [BP], positive regulation of calcium-transporting ATPase activity [BP], positive regulation of optic nerve formation [BP], optic chiasma development [BP], negative regulation of mesenchymal stem cell differentiation [BP], intrinsic apoptotic signaling pathway in response to osmotic stress [BP], negative regulation of dense core granule biogenesis [BP], voltage-gated ion channel activity [MF], left ventricular cardiac muscle tissue morphogenesis [BP], positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction [BP], suramin binding [MF]
CG_ff_promoter_p_RM_12_46_20			2	1.0	1.01E-04	DPEP1, SLC20A1	cellular lactam catabolic process [BP], high affinity inorganic phosphate:sodium symporter activity [MF]
CG_ff_promoter_p_RM_12_182_14			4	0.5	4.61E-04	FADD	apoptotic signaling pathway [BP], extrinsic apoptotic signaling pathway [BP]
CG_ff_promoter_p_RM_14_25_8			4	0.5	3.18E-04	DUT, KLC3	dUTP diphosphatase activity [MF], dUMP biosynthetic process [BP], cardiolipin synthase activity [MF]
CG_ff_promoter_p_RM_12_86_13			5	0.5	1.80E-04	ISL1, F2RL1, PFDN5, APC2	positive regulation of interleukin-1 beta production [BP], positive regulation of interleukin-1 alpha production [BP], interleukin-1 beta secretion [BP], negative regulation of canonical Wnt receptor signaling pathway [BP]
CG_ff_promoter_p_RM_12_14_16			2	1.0	1.19E-04	HMGA2, MIXL1	endodermal cell differentiation [BP]
CG_ff_promoter_p_RM_20_11_2			1	0.5	8.07E-04	PCDHGA8, PCDHGA4, PCDHGA12, PCDHGA5, PCDHGB3	homophilic cell adhesion [BP], calcium ion binding [MF]
CG_ff_promoter_p_RM_20_13_1			1	0.5	1.52E-04	DYNLL2, KCNK3	synaptic target recognition [BP], open rectifier potassium channel activity [MF]
CG_ff_promoter_p_RM_12_399_16			2	0.5	2.48E-04	PIK3CD, ADRA2C, PDPK1	activation of protein kinase B activity [BP], mast cell degranulation [BP]
CG_ff_promoter_p_RM_14_45_9			8	1.0	1.86E-04	PNMT, MOG	phenylethanolamine N-methyltransferase activity [MF], positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP]
CG_ff_promoter_p_RM_12_165_19			2	0.5	2.89E-04	B4GALNT3, B4GALNT4	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [MF]
CG_ff_promoter_p_RM_12_360_5			3	0.5	1.56E-04	GRIK2	regulation of action potential in neuron [BP]
CG_ff_promoter_p_RM_20_3_1			1	0.5	7.51E-04	PCDHA7, PCDHA5, PCDHA13	homophilic cell adhesion [BP], calcium ion binding [MF], cell adhesion [BP]
CG_ff_promoter_p_RM_12_197_11			4	0.5	4.77E-04	RPS21, SNX9	lipid tube assembly [BP], endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP]
CG_ff_promoter_p_RM_12_12_11			1	0.5	3.11E-05	DPEP1, FNDC1	metallodipeptidase activity [MF], positive regulation of cardiac muscle cell apoptotic process [BP], cellular lactam catabolic process [BP]
CG_ff_promoter_p_RM_12_246_13			2	0.5	2.56E-04	HIF1A, AATF	negative regulation of superoxide anion generation [BP], neural fold elevation formation [BP]
CG_ff_promoter_p_RM_14_23_2			2	0.5	2.95E-04	PAK2, ALDH1A3, CHIA	negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [BP], cell wall chitin metabolic process [BP], nucleus accumbens development [BP]
CG_ff_promoter_p_RM_12_342_6			2	0.5	2.61E-04	IDNK	D-gluconate catabolic process [BP], gluconokinase activity [MF]
CG_ff_promoter_p_RM_20_7_2			1	0.5	5.42E-04	PCDHA9, B4GALNT4, PCDHA13, PCDHA5, PCDHA10	homophilic cell adhesion [BP], N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [MF], calcium ion binding [MF], cell adhesion [BP]
CG_ff_promoter_p_RM_12_117_18			4	0.5	2.32E-04	ADORA2A, PRDX5, DRD5, SLIT2, CD38	negative regulation of alpha-beta T cell activation [BP], negative regulation of oxidoreductase activity [BP], regulation of synaptic plasticity [BP], negative regulation of vascular permeability [BP], long term synaptic depression [BP], synaptic transmission, dopaminergic [BP]
CG_ff_promoter_p_RM_12_253_12			3	0.5	2.12E-04	CBX3, TRIM24	nuclear euchromatin [CC]
CG_ff_promoter_p_RM_14_21_4			1	0.5	2.68E-04	ZAP70, UROD	beta selection [BP], uroporphyrinogen decarboxylase activity [MF], T cell aggregation [BP]
CG_ff_promoter_p_RM_14_91_2			2	0.5	2.01E-04	SPHK1, DNAJB6, PSEN2	sphingoid catabolic process [BP], apoptotic process [BP], Z disc [CC]
CG_ff_promoter_p_RM_20_1_4			1	0.5	6.28E-04	NOG, JARID2, EPO, HGSNAT, USP21, ABCG1	heparan-alpha-glucosaminide N-acetyltransferase activity [MF], negative regulation of cytokine activity [BP], sterol-transporting ATPase activity [MF], detection of hormone stimulus [BP], protein kinase activator activity [MF], cellular protein modification process [BP], histone methyltransferase complex [CC], fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP]
CG_ff_promoter_p_RM_12_274_17			2	0.5	2.63E-04	NOS3, FRMD8, LRRFIP1, MICALL1	cytoskeleton [CC]
CG_ff_promoter_p_RM_14_66_2			2	0.5	2.70E-04	CARNS1	carnosine synthase activity [MF], carnosine biosynthetic process [BP]
CG_ff_promoter_p_RM_12_228_9			2	0.5	3.46E-04	TRIB2, CRHR1, IGHMBP2	ATP-dependent 5'-3' RNA helicase activity [MF], corticotrophin-releasing factor receptor activity [MF], corticotropin-releasing hormone receptor activity [MF], corticotropin-releasing hormone binding [MF], negative regulation of interleukin-10 biosynthetic process [BP]
CG_ff_promoter_p_RM_12_113_10			2	0.5	2.15E-04	HIF1AN, ST3GAL3	peptidyl-histidine hydroxylation [BP], N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF], peptidyl-asparagine 3-dioxygenase activity [MF], peptidyl-asparagine hydroxylation [BP], peptidyl-histidine dioxygenase activity [MF]
CG_ff_promoter_p_RM_12_258_12			3	0.5	3.41E-04	AATF, PDE3B, PTF1A	endocrine pancreas development [BP], negative regulation of superoxide anion generation [BP]
CG_ff_promoter_p_RM_12_141_6			2	1.0	1.85E-04	NEFM, SLC9A3R1, CNTNAP1	cytoskeleton organization [BP], axon cargo transport [BP], cellular protein localization [BP]
CG_ff_promoter_p_RM_12_105_8			2	0.5	3.65E-04	CRB3, GREM1	regulation of focal adhesion assembly [BP], cell-cell junction organization [BP]
CG_ff_promoter_p_RM_12_85_4			1	0.5	2.22E-04	RDH10, OSR2, HTRA2, MSX1	embryonic forelimb morphogenesis [BP], middle ear morphogenesis [BP], embryonic digit morphogenesis [BP], pentacyclic triterpenoid metabolic process [BP], ear development [BP], head development [BP], embryonic hindlimb morphogenesis [BP]
CG_ff_promoter_p_RM_12_188_13			3	0.5	2.65E-04	CNTROB, PAFAH1B1, MARK4	centrosome [CC], microtubule organizing center organization [BP], microtubule cytoskeleton organization [BP], brain morphogenesis [BP]
CG_ff_promoter_p_RM_12_27_18			3	1.0	1.39E-04	KCNN2	alpha-actinin binding [MF]
CG_ff_promoter_p_RM_12_147_5			1	0.5	2.56E-04	ZFPM1, LTB4R	negative regulation of interleukin-4 biosynthetic process [BP], leukotriene B4 receptor activity [MF], negative regulation of mast cell differentiation [BP]
CG_ff_promoter_p_RM_12_149_17			2	0.5	1.31E-04	DMRT1	male germ cell proliferation [BP]
CG_ff_promoter_p_RM_12_180_13			3	0.5	1.66E-04	PSEN1, GREM1, RBCK1, RYR1	ossification involved in bone maturation [BP], smooth endoplasmic reticulum [CC], positive regulation of NF-kappaB import into nucleus [BP]
CG_ff_promoter_p_RM_14_62_7			4	0.5	1.97E-04	NQO2, PRKAA2, SMAD6	chromatin binding [MF], dihydronicotinamide riboside quinone reductase activity [MF]
CG_ff_promoter_p_RM_12_370_5			2	0.5	1.90E-04	IDUA, SMPD1	limb morphogenesis [BP], response to cocaine [BP]
CG_ff_promoter_p_RM_12_16_18			1	0.5	8.66E-05	HSD11B2	regulation of blood volume by renal aldosterone [BP], 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [MF]
CG_ff_promoter_p_RM_12_81_12			4	1.0	3.78E-04	PCDHA7, SOX11, TSHZ1, PCDHGA11, PCDHGA12, PCDHGC5, PCDHA10, PCDHA6	homophilic cell adhesion [BP], soft palate development [BP], spinal cord development [BP], cell adhesion [BP]
CG_ff_promoter_p_RM_12_191_13			4	0.5	2.22E-04	SOX2, SLC25A37, MARCKS, CCDC64, SLC12A5	germinal vesicle [CC], detection of mechanical stimulus involved in equilibrioception [BP], thermosensory behavior [BP], Golgi to secretory granule transport [BP], mitochondrial iron ion transport [BP]
CG_ff_promoter_p_RM_14_60_4			8	1.0	9.67E-05	GRIN1, FOXD2, MNAT1, SMARCB1	positive regulation of viral transcription [BP], positive regulation of transcription from RNA polymerase II promoter [BP], propylene metabolic process [BP]
CG_ff_promoter_p_RM_12_263_8			3	0.5	3.29E-04	PPP1R3F, FER, PPP1R3G	regulation of glycogen biosynthetic process [BP], glycogen binding [MF], diapedesis [BP], Fc-epsilon receptor signaling pathway [BP], regulation of glycogen (starch) synthase activity [BP], protein phosphatase binding [MF]
CG_ff_promoter_p_RM_12_78_10			2	0.5	4.24E-04	PDPK1, GTSE1, EMG1, GNAS, TUBA1C	3-phosphoinositide-dependent protein kinase activity [MF], rRNA (pseudouridine) methyltransferase activity [MF], post-embryonic body morphogenesis [BP], cytoplasmic microtubule [CC]
CG_ff_promoter_p_RM_12_142_12			2	0.5	2.55E-04	CHP1, KIRREL	negative regulation of protein phosphorylation [BP]
CG_ff_promoter_p_RM_12_10_16			3	1.0	2.58E-04	TBXAS1	thromboxane-A synthase activity [MF]
CG_ff_promoter_p_RM_12_303_15			3	0.5	3.50E-04	ID1, SKIL, PFKP, PFKL	6-phosphofructokinase activity [MF], 6-phosphofructokinase complex [CC], fructose 6-phosphate metabolic process [BP], response to antibiotic [BP]
CG_ff_promoter_p_RM_12_173_15			2	0.5	2.29E-04	WNT2B	neuron differentiation [BP]
CG_ff_promoter_p_RM_14_8_6			3	0.5	5.30E-04	TCF7, DMBX1, FOXF2, ATF7IP, PRDM16	central nervous system development [BP], sequence-specific DNA binding [MF], transcription factor complex [CC]
CG_ff_promoter_p_RM_14_95_2			1	0.5	2.72E-04	SOX8, PRMT6, IQGAP2, KIF26B, SPAG6	ureteric bud invasion [BP], peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [BP], histone methyltransferase activity (H3-R2 specific) [MF], retinal rod cell differentiation [BP], microtubule [CC], histone methyltransferase activity (H2A-R3 specific) [MF], histone H3-R2 methylation [BP]
CG_ff_promoter_p_RM_14_42_2			4	0.5	8.38E-05	C1QB, IDUA, GPX4	phospholipid-hydroperoxide glutathione peroxidase activity [MF], L-iduronidase activity [MF], complement component C1 complex [CC]
CG_ff_promoter_p_RM_12_101_8			3	0.5	3.39E-04	HES1	negative regulation of pancreatic A cell differentiation [BP], N-box binding [MF], negative regulation of stomach neuroendocrine cell differentiation [BP], positive regulation of mitotic cell cycle, embryonic [BP], lateral inhibition [BP]
CG_ff_promoter_p_RM_12_145_7			2	0.5	2.06E-04	KHK	ketohexokinase activity [MF]
CG_ff_promoter_p_RM_12_321_4			2	0.5	7.68E-05	UBA5, PAPSS2	sulfate adenylyltransferase (ATP) activity [MF], UFM1 activating enzyme activity [MF], adenylylsulfate kinase activity [MF], 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [BP]
CG_ff_promoter_p_RM_12_133_5			1	0.5	6.59E-05	ZNF134, ZNF551, ZNF586, DOT1L	DNA binding [MF], regulation of transcription regulatory region DNA binding [BP]
CG_ff_promoter_p_RM_12_222_7			1	0.5	3.56E-04	DRAXIN, SLC18A2	serotonin transmembrane transporter activity [MF], monoamine transmembrane transporter activity [MF], commissural neuron differentiation in spinal cord [BP], clathrin-sculpted monoamine transport vesicle membrane [CC]
CG_ff_promoter_p_RM_12_206_9			3	0.5	2.30E-04	RAMP1, HTRA2, TRAF3	CD40 receptor complex [CC], receptor complex [CC]
CG_ff_promoter_p_RM_12_281_8			3	0.5	3.48E-04	CXADR	transepithelial transport [BP]
CG_ff_promoter_p_RM_12_336_10			3	0.5	1.51E-04	PRKCG, APOE	positive regulation of mismatch repair [BP], positive regulation of low-density lipoprotein particle receptor catabolic process [BP], metal chelating activity [MF]
CG_ff_promoter_p_RM_12_178_23			3	0.5	3.41E-04	ACVRL1, DBNL, SMAD4, ATP1B3, FMN2, DVL3, ATP1A1, WWOX, EPB41, SPTBN4, MLPH, TGFBR2	cellular response to transforming growth factor beta stimulus [BP], cell cortex [CC], spectrin binding [MF], cortical actin cytoskeleton [CC], transforming growth factor beta binding [MF], response to transforming growth factor beta stimulus [BP], spectrin [CC], sodium:potassium-exchanging ATPase complex [CC], pathway-restricted SMAD protein phosphorylation [BP], sodium:potassium-exchanging ATPase activity [MF]
CG_ff_promoter_p_RM_12_140_18			2	0.5	1.53E-04	B3GALT6, F2	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP], Golgi medial cisterna [CC], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF]
CG_ff_promoter_p_RM_12_26_31			3	1.0	6.23E-05	CPS1, AMD1, GATA4	S-adenosylmethioninamine biosynthetic process [BP], lung lobe formation [BP], carbamoyl-phosphate synthase (ammonia) activity [MF], adenosylmethionine decarboxylase activity [MF]
CG_ff_promoter_p_RM_12_361_10			3	0.5	1.48E-04	PICK1	receptor clustering [BP]
CG_ff_promoter_p_RM_12_115_14			4	0.5	3.05E-04	CR2, TMPO, YY1, CIRH1A, TACC1, TACC3, ID1, SRR, TYMS, INHBB, FOXF1, DYNLL1, YAP1, PKNOX2, ZNF771, ARID3A	interkinetic nuclear migration [BP], lung vasculature development [BP], protein dimerization activity [MF], lateral mesoderm development [BP], regulation of transcription, DNA-dependent [BP], cerebral cortex development [BP], protein homodimerization activity [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_p_RM_12_74_11			2	0.5	1.38E-04	HSD3B7, KIF26A, UGCG	glucosylceramide biosynthetic process [BP], cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF], ceramide glucosyltransferase activity [MF], regulation of cell growth by extracellular stimulus [BP]
CG_ff_promoter_p_RM_12_404_7			2	0.5	1.88E-04	GATA3	otic vesicle development [BP]
CG_ff_promoter_p_RM_12_70_20			3	1.0	1.56E-04	HDAC6, ADRA2A, GPX4, AQP1, PNP	NAD biosynthesis via nicotinamide riboside salvage pathway [BP], cellular response to hydrogen peroxide [BP], carbon dioxide transmembrane transporter activity [MF], maintenance of symbiont-containing vacuole by host [BP], phospholipid-hydroperoxide glutathione peroxidase activity [MF], inosine catabolic process [BP], nicotinamide riboside catabolic process [BP], transepithelial water transport [BP], dynein complex binding [MF], negative regulation of adrenergic receptor signaling pathway [BP], purine-nucleoside phosphorylase activity [MF], phospholipase C-activating adrenergic receptor signaling pathway [BP], carbon dioxide transmembrane transport [BP], Hsp90 deacetylation [BP], adenylate cyclase-inhibiting adrenergic receptor signaling pathway [BP], nitric oxide transmembrane transporter activity [MF]
CG_ff_promoter_p_RM_12_215_12			2	0.5	2.31E-04	SP100, MAPT	nuclear periphery [CC]
CG_ff_promoter_p_RM_12_287_8			2	0.5	1.43E-04	F2RL1, SPTBN4, CHAT, ADAM22, SQSTM1	choline O-acetyltransferase activity [MF], adult walking behavior [BP], positive regulation of eosinophil degranulation [BP], adult locomotory behavior [BP], chemokine (C-C motif) ligand 2 secretion [BP], positive regulation of neutrophil mediated killing of gram-negative bacterium [BP], negative regulation of chemokine secretion [BP], positive regulation of renin secretion into blood stream [BP], cell differentiation [BP]
CG_ff_promoter_p_RM_12_198_12			4	0.5	1.45E-04	PTX3	(1->3)-beta-D-glucan binding [MF]
CG_ff_promoter_p_RM_12_41_20			1	0.5	1.09E-04	MICB, MICA, AQP1, SGPL1	carbon dioxide transmembrane transporter activity [MF], sphinganine-1-phosphate aldolase activity [MF], natural killer cell lectin-like receptor binding [MF], maintenance of symbiont-containing vacuole by host [BP], transepithelial water transport [BP], MHC class I protein complex [CC], gamma-delta T cell activation [BP], carbon dioxide transmembrane transport [BP], cytolysis [BP], nitric oxide transmembrane transporter activity [MF]
CG_ff_promoter_p_RM_12_131_15			2	0.5	3.34E-04	MTAP, ENOPH1	L-methionine salvage from methylthioadenosine [BP], polyamine metabolic process [BP]
CG_ff_promoter_p_RM_14_1_8			3	0.5	3.25E-04	GREM1, KCNK3, SMO, HES1, ID1, AGRN	negative regulation of stomach neuroendocrine cell differentiation [BP], BMP signaling pathway [BP], lateral inhibition [BP], blood vessel morphogenesis [BP], ureteric bud morphogenesis [BP], endocrine pancreas development [BP], blood vessel endothelial cell migration [BP], protein localization to nucleus [BP], positive regulation of synaptic growth at neuromuscular junction [BP], mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP], negative regulation of bone trabecula formation [BP], ventral midline determination [BP], detection of cell density by contact stimulus involved in contact inhibition [BP], negative regulation of bone mineralization involved in bone maturation [BP], receptor clustering [BP], cochlea development [BP], positive regulation of branching involved in ureteric bud morphogenesis [BP], adenohypophysis development [BP], heart development [BP], cardioblast differentiation [BP], embryonic heart tube morphogenesis [BP], regulation of heart morphogenesis [BP], renal system development [BP], otolith morphogenesis [BP], negative regulation of DNA binding [BP], neuron fate commitment [BP], cell morphogenesis [BP], branching involved in ureteric bud morphogenesis [BP], positive regulation of transcription from RNA polymerase II promoter [BP], positive regulation of mitotic cell cycle, embryonic [BP], mesenchymal to epithelial transition involved in metanephros morphogenesis [BP], N-box binding [MF], negative regulation of pancreatic A cell differentiation [BP], cell-cell signaling [BP], hindbrain morphogenesis [BP], open rectifier potassium channel activity [MF], positive regulation of protein import into nucleus [BP]
CG_ff_promoter_p_RM_12_295_16			3	0.5	1.97E-04	OAZ1, PAOX	polyamine biosynthetic process [BP]
CG_ff_promoter_p_RM_12_125_7			2	0.5	1.45E-04	MARC2, MARC1	detoxification of nitrogen compound [BP], molybdenum ion binding [MF], molybdopterin cofactor binding [MF], nitrate reductase activity [MF], nitrate metabolic process [BP]
CG_ff_promoter_p_RM_12_67_9			1	0.5	2.73E-04	BCAM	laminin receptor activity [MF], cell-matrix adhesion [BP]
CG_ff_promoter_p_RM_14_40_11			2	0.5	3.06E-04	SP1, ARF6, ADRA2A, ALKBH5, PHF2, OGFOD1	liver development [BP], oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [MF], thioesterase binding [MF]
CG_ff_promoter_p_RM_12_220_17			2	0.5	3.53E-04	ZIC2	developmental pigmentation [BP]
CG_ff_promoter_p_RM_14_5_8			3	0.5	2.53E-04	PLEKHF1, MPP5, LYN	positive regulation of oligodendrocyte progenitor proliferation [BP], alpha2-beta1 integrin complex [CC], protein localization to myelin sheath abaxonal region [BP], positive regulation of dendritic cell apoptotic process [BP], negative regulation of mast cell proliferation [BP], protein localization to plasma membrane [BP]
CG_ff_promoter_p_RM_12_167_8			4	0.5	1.36E-04	FOXJ2, BCL2L11, NAT8L	tube formation [BP], embryo development [BP], aspartate N-acetyltransferase activity [MF]
CG_ff_promoter_p_RM_12_211_10			2	0.5	5.13E-04	SLC12A2, IRF8, ASIC1, NOD2, CDCA8, CATSPER4	positive regulation of interleukin-12 production [BP], chromosome, centromeric region [CC], negative regulation of growth of symbiont in host [BP], sodium ion transport [BP]
CG_ff_promoter_p_RM_12_344_6			1	0.5	1.93E-04	DLL4, DNM1L	membrane fission involved in mitochondrial fission [BP], cellular component disassembly involved in execution phase of apoptosis [BP], regulation of peroxisome organization [BP], dynamin polymerization involved in mitochondrial fission [BP], blood vessel lumenization [BP]
CG_ff_promoter_p_RM_14_7_3			3	0.5	4.48E-04	HOXC8, DLX1, PPIA, RAD23A, SOX2	forebrain neuron differentiation [BP], positive regulation of viral genome replication [BP], transcription regulatory region sequence-specific DNA binding [MF]
CG_ff_promoter_p_RM_12_59_19			2	1.0	2.08E-04	CACNA1C, OPRL1, MPG	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF], caveolar macromolecular signaling complex [CC], nociceptin receptor activity [MF], calcium-mediated signaling using extracellular calcium source [BP]
CG_ff_promoter_p_RM_14_114_6			1	0.5	4.33E-04	HTRA2	pentacyclic triterpenoid metabolic process [BP]
CG_ff_promoter_p_RM_12_324_10			1	0.5	7.13E-05	RASGRP3, PCDHAC2, KIR2DL1, KIR2DL4, GATA4, KIR3DL2, FCAR	regulation of immune response [BP], cellular defense response [BP], natural killer cell inhibitory signaling pathway [BP], lung lobe formation [BP], integral to plasma membrane [CC], immune response [BP]
CG_ff_promoter_p_RM_14_36_10			8	1.0	5.24E-05	RPS11, YY1, ACSL3	positive regulation of phosphatidylcholine biosynthetic process [BP], RNA metabolic process [BP], response to prostaglandin F stimulus [BP]
CG_ff_promoter_p_RM_14_112_2			2	0.5	3.47E-04	SPHK1, IL15, STIM1	extrathymic T cell selection [BP], sphingoid catabolic process [BP], cortical endoplasmic reticulum [CC]
CG_ff_promoter_p_RM_12_372_27			4	0.5	3.24E-04	PPM1L, HGS, CSNK1G2, NDFIP2, PLEKHB2, RAB12, SGPP2, ZFYVE27	sphingolipid biosynthetic process [BP], protein localization to plasma membrane [BP], multivesicular body membrane [CC], recycling endosome membrane [CC]
CG_ff_promoter_p_RM_12_383_8			4	0.5	3.18E-04	EPHB1, JAM3, SOX11, TET2, HOXD3, NIPBL, PSEN2, EDNRA, KCNIP3, ARID3A	membrane raft [CC], embryonic skeletal system morphogenesis [BP], embryonic digestive tract morphogenesis [BP], kidney development [BP], sensory perception of pain [BP], regulation of neutrophil chemotaxis [BP], establishment of cell polarity [BP]
CG_ff_promoter_p_RM_12_233_11			4	0.5	3.95E-04	CD1D, AP1AR, NR2E1, MGAT2, FOXO3	regulation of Arp2/3 complex-mediated actin nucleation [BP], amygdala development [BP], alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], initiation of primordial ovarian follicle growth [BP], antigen processing and presentation, endogenous lipid antigen via MHC class Ib [BP]
CG_ff_promoter_p_RM_14_47_5			4	0.5	2.72E-04	FOXG1	regulation of mitotic cell cycle [BP]
CG_ff_promoter_p_RM_12_61_8			2	1.0	2.21E-04	SSTR2, IGHMBP2, PDE1B, HTR5A	ATP-dependent 5'-3' RNA helicase activity [MF], G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [BP], calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [MF]
CG_ff_promoter_p_RM_12_84_13			3	0.5	3.13E-04	RNF4	nucleosome binding [MF]
CG_ff_promoter_p_RM_12_168_7			2	0.5	4.06E-04	CROT	carnitine O-octanoyltransferase activity [MF]
CG_ff_promoter_p_RM_12_226_11			2	1.0	2.54E-04	TRIB2, CD1C	T cell activation involved in immune response [BP], negative regulation of interleukin-10 biosynthetic process [BP]
CG_ff_promoter_p_RM_14_41_5			3	0.5	1.53E-04	MDM2	cellular response to alkaloid [BP]
CG_ff_promoter_p_RM_14_28_14			6	1.0	3.79E-04	GADD45B, FOXO3	response to stress [BP]
CG_ff_promoter_p_RM_12_48_12			1	0.5	3.37E-05	LPL	chylomicron remodeling [BP], triglyceride binding [MF]
CG_ff_promoter_p_RM_12_351_11			4	0.5	1.59E-04	MPG, SLC12A5	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], thermosensory behavior [BP], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF]
CG_ff_promoter_p_RM_14_20_2			2	0.5	2.42E-04	GATA3, SHROOM2	parathyroid hormone secretion [BP], negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], regulation of cellular response to X-ray [BP], positive regulation of interleukin-13 secretion [BP], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], pro-T cell differentiation [BP], negative regulation of cell proliferation involved in mesonephros development [BP], eye pigment granule organization [BP], positive regulation of interleukin-5 secretion [BP], regulation of histone H3-K27 methylation [BP], canonical Wnt receptor signaling pathway involved in metanephric kidney development [BP], lens development in camera-type eye [BP]
CG_ff_promoter_p_RM_14_63_5			1	0.5	3.23E-04	IST1, CRHR1, PRKCI	corticotropin-releasing hormone receptor activity [MF], polarisome [CC], virus budding from nuclear membrane by viral capsid re-envelopment [BP]
CG_ff_promoter_p_RM_12_104_14			3	0.5	2.79E-04	GATA4, ASS1, MERTK, SMAD4	SMAD protein signal transduction [BP], rhabdomere [CC], transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [MF], argininosuccinate synthase activity [MF], positive regulation of BMP signaling pathway [BP], lung lobe formation [BP], gastrulation with mouth forming second [BP]
CG_ff_promoter_p_RM_12_318_7			1	0.5	3.84E-04	NOG	negative regulation of cytokine activity [BP], fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP]
CG_ff_promoter_p_RM_16_13_16			3	0.5	5.23E-04	LMO4, JARID2, SETD1B, MLL5, MAPKAPK2, USP21, EHMT1, HDGFRP2, ZNF532, RB1, ATOH1, KCNIP3, ARNTL, PRMT8, SNAPC2, PKNOX1, ABCG1, GNAS, GRIK2, INSM2, ADRB1, NELFB	transcription from RNA polymerase II promoter [BP], histone methylation [BP], regulation of inhibitory postsynaptic membrane potential [BP], regulation of transcription, DNA-dependent [BP], DNA methylation [BP], transcription, DNA-dependent [BP], histone-lysine N-methyltransferase activity [MF], protein-lysine N-methyltransferase activity [MF], RNA metabolic process [BP], erythrocyte differentiation [BP], S-adenosylmethionine-dependent methyltransferase activity [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_ff_promoter_p_RM_12_241_22			2	0.5	6.96E-04	FZD7	negative regulation of ectodermal cell fate specification [BP]
CG_ff_promoter_p_RM_12_352_11			2	0.5	1.22E-04	PLEKHF1, HIF1AN, KIF5A, GADD45B, STK11, BBS5, CDKN1B, BCAP29	phosphatidylinositol-3-phosphate binding [MF], cell death [BP], negative regulation of epithelial cell proliferation involved in prostate gland development [BP], apoptotic process [BP], peptidyl-histidine dioxygenase activity [MF], peptidyl-asparagine 3-dioxygenase activity [MF]
CG_ff_promoter_p_RM_14_24_5			3	0.5	3.62E-04	MAP2K1, PRKCE, RBM15, LRP5, ITGB8	ganglioside metabolic process [BP], placenta blood vessel development [BP], regulation of insulin secretion involved in cellular response to glucose stimulus [BP], receptor signaling protein tyrosine phosphatase activity [MF]
CG_ff_promoter_p_RM_12_235_11			2	0.5	2.83E-04	SMARCB1, P2RX2, RLF	DNA integration [BP], phosphatidylinositol binding [MF], retroviral genome replication [BP]
CG_ff_promoter_p_RM_12_219_21			1	0.5	1.36E-04	FBXL7, FBXO9	SCF ubiquitin ligase complex [CC], SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_ff_promoter_p_RM_12_319_15			3	0.5	2.69E-04	CCND2, PKD2, RYR2	intracellular ligand-gated calcium channel activity [MF], positive regulation of cyclin-dependent protein kinase activity [BP], calcium-release channel activity [MF], calcium-induced calcium release activity [MF]
CG_ff_promoter_p_RM_12_40_10			1	0.5	3.62E-04	TTLL3, AIP	protein-glycine ligase activity [MF], GAF domain binding [MF], protein polyglycylation [BP], protein-glycine ligase activity, initiating [MF]
CG_ff_promoter_p_RM_12_276_10			2	0.5	2.90E-04	NME2	protein histidine kinase activity [MF]
CG_ff_promoter_p_RM_12_196_8			3	1.0	1.28E-04	CHRNB2, PDPK1	3-phosphoinositide-dependent protein kinase activity [MF], lateral geniculate nucleus development [BP]
CG_ff_promoter_p_RM_12_384_14			4	0.5	6.46E-04	ESPN	parallel actin filament bundle assembly [BP]
CG_ff_promoter_p_RM_12_312_9			1	0.5	5.62E-04	PTK2B	marginal zone B cell differentiation [BP], 3-phosphoinositide-dependent protein kinase binding [MF], positive regulation of B cell chemotaxis [BP], regulation of cGMP-mediated signaling [BP]
CG_ff_promoter_p_RM_12_33_13			2	1.0	4.16E-04	CHP1, KIF26A, ARID1A	nucleosome mobilization [BP], microtubule binding [MF]
CG_ff_promoter_p_RM_12_160_14			4	0.5	2.95E-04	ZFPM1, IGF1R	negative regulation of interleukin-4 biosynthetic process [BP], inactivation of MAPKK activity [BP], negative regulation of mast cell differentiation [BP]
CG_ff_promoter_p_RM_14_65_6			4	0.5	4.97E-05	APOC1, POU3F3	metanephric macula densa development [BP], negative regulation of phosphatidylcholine catabolic process [BP]
CG_ff_promoter_p_RM_12_251_12			2	0.5	2.80E-04	FOXE1, MAML1, TSHZ1	soft palate development [BP], intracellular membrane-bounded organelle [CC]
CG_ff_promoter_p_RM_16_9_5			2	1.0	2.06E-04	CENPA	condensed chromosome inner kinetochore [CC]
CG_ff_promoter_p_RM_12_192_7			4	0.5	2.44E-04	KIF26A, FOXD3	enteric nervous system development [BP]
CG_ff_promoter_p_RM_16_5_5			2	1.0	1.34E-04	IL24	serine phosphorylation of STAT3 protein [BP]
CG_ff_promoter_p_RM_12_322_11			2	0.5	7.75E-05	BCR, PSMD9	negative regulation of neutrophil degranulation [BP], proteasome regulatory particle, base subcomplex [CC]
CG_ff_promoter_p_RM_12_194_6			2	0.5	2.57E-04	FZD1, JMY, VEGFA, FGFR3, NR2C2	lung development [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP], meiotic cell cycle [BP], lung alveolus development [BP], negative regulation of mitosis [BP]
CG_ff_promoter_p_RM_12_264_9			3	0.5	3.73E-04	RAB10, GRIN1, PAN3	establishment of protein localization to endoplasmic reticulum membrane [BP], positive regulation of cytoplasmic mRNA processing body assembly [BP], propylene metabolic process [BP]
CG_ff_promoter_p_RM_12_314_9			2	0.5	3.42E-04	NKD2	Golgi vesicle fusion to target membrane [BP]
CG_ff_promoter_p_RM_12_229_9			1	0.5	4.49E-04	INHBB	negative regulation of hepatocyte growth factor biosynthetic process [BP], host cell surface receptor binding [MF]
CG_ff_promoter_p_RM_12_304_11			4	0.5	1.35E-04	PKD2	renal tubule morphogenesis [BP]
CG_ff_promoter_p_RM_12_181_19			2	0.5	2.88E-04	RNASE2, EGFR, RNASE3	protein insertion into membrane [BP], pancreatic ribonuclease activity [MF]
CG_ff_promoter_p_RM_12_256_12			3	0.5	3.06E-04	FAH	fumarylacetoacetase activity [MF]
CG_ff_promoter_p_RM_12_44_5			1	0.5	1.74E-04	DRAXIN	commissural neuron differentiation in spinal cord [BP]
CG_ff_promoter_p_RM_12_29_21			5	1.0	6.43E-05	FOXL1	visceral mesoderm-endoderm interaction involved in midgut development [BP]
CG_ff_promoter_p_RM_12_357_16			2	1.0	1.91E-04	GATA1	enhancer sequence-specific DNA binding [MF]
CG_ff_promoter_p_RM_12_47_12			3	1.0	9.22E-05	ATP5C1, CPA2	transmembrane transporter activity [MF], vacuolar protein catabolic process [BP]
CG_ff_promoter_p_RM_14_26_30			6	1.0	2.48E-04	SEC14L5, PSME1, PIAS3, PRKCSH, RPS9, TDRD9	intracellular [CC], RNA metabolic process [BP], nucleic acid binding [MF]
CG_ff_promoter_p_RM_12_122_11			3	0.5	3.20E-04	DCAF17, DCAF6, ZFPM1	granulocyte differentiation [BP], Cul4-RING ubiquitin ligase complex [CC]
CG_ff_promoter_p_RM_12_25_28			4	1.0	4.57E-05	SPTBN4, MT3	positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [BP], positive regulation of oxygen metabolic process [BP], cadmium ion homeostasis [BP], clustering of voltage-gated sodium channels [BP], cell body fiber [CC], fertilization [BP], positive regulation of lysosomal membrane permeability [BP], axon hillock [CC]
CG_ff_promoter_p_RM_16_1_2			1	0.5	6.83E-04	HIST1H2AH, HIST1H2AC, HIST1H2BO	nucleosome assembly [BP], nucleosome [CC], protein heterodimerization activity [MF]
CG_ff_promoter_p_RM_12_285_11			3	0.5	4.21E-04	VEGFA, EIF3L	positive regulation of peptidyl-tyrosine autophosphorylation [BP], basophil chemotaxis [BP], positive regulation of p38MAPK cascade [BP], vascular endothelial growth factor receptor 1 binding [MF], coronary vein morphogenesis [BP], fibrillar center [CC]
CG_ff_promoter_p_RM_12_257_8			2	0.5	2.44E-04	ALPL, SMAD5, BMPR1A, BMP6	bone development [BP], positive regulation of osteoblast differentiation [BP], osteoblast differentiation [BP], BMP signaling pathway [BP], positive regulation of pathway-restricted SMAD protein phosphorylation [BP], positive regulation of bone mineralization [BP], endochondral ossification [BP], Mullerian duct regression [BP], developmental process involved in reproduction [BP]
CG_ff_promoter_p_RM_14_80_2			2	0.5	3.15E-04	LHX9, NOG, MLL5, GNAS, ZHX2	motor neuron axon guidance [BP], somatic stem cell maintenance [BP], DNA methylation [BP]
CG_ff_promoter_p_RM_16_7_2			1	0.5	1.68E-04	PCDHA7, PCDHA5, PVRL3, SC5DL, PCDHA10, GPD1L, PCDHA13, EWSR1, PCDHA6	negative regulation of protein kinase C signaling cascade [BP], lathosterol oxidase activity [MF], plasma membrane [CC], cell adhesion [BP], homophilic cell adhesion [BP], calcium ion binding [MF], cholesterol biosynthetic process via lathosterol [BP]
CG_ff_promoter_p_RM_14_82_6			2	0.5	3.44E-04	IGF1R, EP400, BASP1, FRG1	regulation of JNK cascade [BP], neuron projection [CC], nuclear speck [CC]
CG_ff_promoter_p_RM_12_169_10			4	0.5	2.73E-04	NOS3, CENPA, ZKSCAN7, CUL1, ZKSCAN1	interaction with host [BP], virus-host interaction [BP], viral reproduction [BP]
CG_ff_promoter_p_RM_12_330_9			3	0.5	2.60E-04	ZFYVE9, FOXI2, RBPMS, BBX, KDM2A	SMAD protein import into nucleus [BP], regulation of transcription, DNA-dependent [BP], regulation of sequence-specific DNA binding transcription factor activity [BP]
CG_ff_promoter_p_RM_12_279_10			2	0.5	2.79E-04	CHAC1, HERPUD1	response to unfolded protein [BP]
CG_ff_promoter_p_RM_12_270_13			3	0.5	2.30E-04	KIT, LYN	receptor signaling protein tyrosine kinase activity [MF], mast cell proliferation [BP], signal transduction by phosphorylation [BP]
CG_ff_promoter_p_RM_12_332_7			3	0.5	2.57E-04	SESN2, ZNF57, PABPN1, RABL6, KLF13, SOX11, UFM1, RPS6KB1, ZNF346, TMEM57, WEE1, IRX6, TCF7, SPATA18, HOXD1, HIST3H2BB, GATA3, YAP1, ARID3A, PNLDC1, PTMA, CD3EAP, ACAD9, SPAG16, PRDM6, EIF4EBP1, ATF4, PHF3, ZNF771, RNF11	cellular response to interleukin-4 [BP], nucleus [CC], intracellular membrane-bounded organelle [CC], TOR signaling cascade [BP]
CG_ff_promoter_p_RM_12_242_7			2	0.5	7.11E-04	NOD2	negative regulation of interleukin-18 production [BP], muramyl dipeptide binding [MF], macrophage inflammatory protein-1 alpha production [BP], positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [BP], positive regulation of dendritic cell cytokine production [BP], detection of muramyl dipeptide [BP], activation of MAPK activity involved in innate immune response [BP], microglial cell activation involved in immune response [BP], pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response [BP], positive regulation of prostaglandin-E synthase activity [BP]
CG_ff_promoter_p_RM_14_68_6			2	1.0	1.21E-04	FICD, NUP205, OBSCN	protein adenylylation [BP], regulation of Rho protein signal transduction [BP], protein adenylyltransferase activity [MF], protein import into nucleus, docking [BP]
CG_ff_promoter_p_RM_12_207_9			2	0.5	2.96E-04	RYR2, ARID1A, FN3K	fructoselysine metabolic process [BP], positive regulation of calcium-transporting ATPase activity [BP], intrinsic apoptotic signaling pathway in response to osmotic stress [BP], fructosamine-3-kinase activity [MF], nucleosome mobilization [BP], left ventricular cardiac muscle tissue morphogenesis [BP], positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction [BP], suramin binding [MF]
CG_ff_promoter_p_RM_12_338_10			2	1.0	8.44E-05	CAPN7	self proteolysis [BP]
CG_ff_promoter_p_RM_14_6_3			3	0.5	1.59E-04	TMTC3, INPPL1, PSEN1	post-embryonic development [BP]
CG_ff_promoter_p_RM_12_417_11			2	1.0	1.22E-04	STEAP1	iron ion homeostasis [BP]
CG_ff_promoter_p_RM_14_4_2			1	0.5	1.54E-04	CARM1, RPIA	histone H3-R17 methylation [BP], histone methyltransferase activity (H3-R17 specific) [MF], ribose-5-phosphate isomerase activity [MF]
CG_ff_promoter_p_RM_14_38_4			4	0.5	2.60E-04	ICAM1, HTR6	response to sulfur dioxide [BP], T cell antigen processing and presentation [BP], negative regulation of acetylcholine secretion [BP], cell adhesion mediated by integrin [BP], negative regulation of gamma-aminobutyric acid secretion [BP]
CG_ff_promoter_p_RM_14_86_7			2	0.5	3.79E-04	CYR61, PPP4R4, ZFPM1, AP2M1, OVOL1, AACS, NNT, RAB7A	regulation of protein serine/threonine phosphatase activity [BP], NAD(P)+ transhydrogenase (B-specific) activity [MF], atrioventricular valve morphogenesis [BP], NAD(P)+ transhydrogenase (AB-specific) activity [MF], negative regulation of epidermal growth factor receptor signaling pathway [BP], intussusceptive angiogenesis [BP], atrial septum morphogenesis [BP], acetoacetate-CoA ligase activity [MF], negative regulation of mast cell differentiation [BP], epidermal growth factor catabolic process [BP], ventricular septum development [BP], negative regulation of interleukin-4 biosynthetic process [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF]
CG_ff_promoter_p_RM_14_34_4			2	0.5	3.02E-04	NTMT1	N-terminal peptidyl-alanine trimethylation [BP], N-terminal peptidyl-serine trimethylation [BP], N-terminal peptidyl-serine dimethylation [BP], N-terminal peptidyl-proline dimethylation [BP]
CG_ff_promoter_p_RM_12_382_16			4	0.5	4.00E-04	MAP2K1, ABCG1, TAF1B	RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity [MF], RNA polymerase I CORE element sequence-specific DNA binding [MF], sterol-transporting ATPase activity [MF], receptor signaling protein tyrosine phosphatase activity [MF]
CG_ff_promoter_p_RM_12_378_8			3	0.5	2.78E-04	ICT1, PAX2, CREBRF	vestibulocochlear nerve formation [BP], positive regulation of optic nerve formation [BP], optic chiasma development [BP], translation release factor activity, codon nonspecific [MF], negative regulation of endoplasmic reticulum unfolded protein response [BP], mitochondrial translational termination [BP]
CG_ff_promoter_p_RM_12_365_12			2	0.5	3.44E-04	RXRA, MOCS3	vitamin metabolic process [BP]
CG_ff_promoter_p_RM_12_171_10			2	0.5	1.74E-04	TRIB2, ID4	negative regulation of fat cell differentiation [BP]
CG_ff_promoter_p_RM_12_97_16			2	0.5	3.45E-04	WFS1, KLF2, MAP2K5, WBP2NL	positive regulation of growth [BP], egg activation [BP], cellular response to laminar fluid shear stress [BP]
CG_ff_promoter_p_RM_14_107_20			3	0.5	4.41E-04	AGGF1, PRMT8, GNAS, BHLHE40, ARNTL, MLL5, ADM, FOXC1, EHMT1	circadian regulation of gene expression [BP], vasculogenesis [BP], histone methylation [BP], DNA methylation [BP]
CG_ff_promoter_p_RM_14_2_4			3	0.5	2.46E-04	APOC1, SAA1	high-density lipoprotein particle [CC]
CG_ff_promoter_p_RM_12_82_13			1	0.5	3.39E-04	WFS1, MED25, SLC12A5	positive regulation of chromatin binding [BP], positive regulation of mediator complex assembly [BP], thermosensory behavior [BP], negative regulation of type B pancreatic cell apoptotic process [BP]
CG_ff_promoter_p_RM_14_88_3			1	0.5	2.84E-04	PAK2	negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [BP]
CG_ff_promoter_p_RM_12_66_14			2	0.5	2.26E-04	CD3E, INPP5D	T cell receptor signaling pathway [BP], alpha-beta T cell receptor complex [CC], negative regulation of neutrophil differentiation [BP], SH3 domain binding [MF]
CG_ff_promoter_p_RM_12_201_17			2	0.5	2.92E-04	LMO4	regulation of cell fate specification [BP]
CG_ff_promoter_p_RM_14_46_5			6	1.0	1.89E-04	PAX2, ZFAND6	polyubiquitin binding [MF], positive regulation of optic nerve formation [BP], optic chiasma development [BP], vestibulocochlear nerve formation [BP]
CG_ff_promoter_p_RM_12_266_16			2	0.5	1.72E-04	BUB3, EFNA2, TOP1, SLC34A1, ILF3, VSX2, CTCF, BCL2L11	regulation of chromosome segregation [BP], BIM-BCL-2 complex [CC], BIM-BCL-xl complex [CC], chromosome segregation [BP], replication fork protection complex [CC], bone remodeling [BP], nucleolus [CC], chromatin insulator sequence binding [MF]
CG_ff_promoter_p_RM_12_13_16			1	0.5	2.68E-04	ACADM, NOX5	medium-chain-acyl-CoA dehydrogenase activity [MF], medium-chain fatty acid catabolic process [BP], regulation of fusion of sperm to egg plasma membrane [BP], flavin adenine dinucleotide binding [MF]
CG_ff_promoter_p_RM_12_203_13			3	0.5	2.71E-04	ZNF324, PRDM8, SOX12, ZFPM1, POLR2F, SALL3, SPIN1, NFX1	DNA binding [MF]
CG_ff_promoter_p_RM_12_8_10			2	1.0	1.82E-04	ID2, OSR2, ABP1	cellular response to copper ion starvation [BP], positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP], cellular response to azide [BP], metanephros development [BP]
CG_ff_promoter_p_RM_12_162_18			2	0.5	2.42E-04	IL4R, FLVCR1	ovulation [BP], heme export [BP]
CG_ff_promoter_p_RM_12_316_11			2	0.5	2.43E-04	CHAT, COMT	neurotransmitter biosynthetic process [BP]
CG_ff_promoter_p_RM_12_21_7			1	0.5	8.10E-05	SRGN, ACOT4, ACOT2, AVPR1B	long-chain fatty acid metabolic process [BP], very long-chain fatty acid metabolic process [BP], succinyl-CoA hydrolase activity [MF], acyl-CoA hydrolase activity [MF], maintenance of granzyme B location in T cell secretory granule [BP], palmitoyl-CoA hydrolase activity [MF], unsaturated monocarboxylic acid metabolic process [BP], saturated monocarboxylic acid metabolic process [BP], mast cell secretory granule organization [BP], T cell secretory granule organization [BP], regulation of systemic arterial blood pressure by vasopressin [BP], acyl-CoA metabolic process [BP], maintenance of protease location in mast cell secretory granule [BP], carboxylesterase activity [MF]
CG_ff_promoter_p_RM_14_52_14			3	0.5	1.87E-04	ZNF440, TRIM72, SP2, ZNF844, TRAF2, ZNF69, PCGF3	zinc ion binding [MF]
CG_ff_promoter_p_RM_12_331_11			3	0.5	2.00E-04	PDGFRA	platelet aggregation [BP]
CG_ff_promoter_p_RM_12_394_9			1	0.5	3.66E-04	PPP1CB, PTGDR	myosin phosphatase activity [MF], cellular response to prostaglandin D stimulus [BP], myosin-light-chain-phosphatase activity [MF]
CG_ff_promoter_p_RM_12_313_6			1	0.5	9.43E-05	KCNN1	potassium ion transport [BP]
CG_ff_promoter_p_RM_12_419_13			2	0.5	2.73E-04	FN3K, BMPR1A	fructosamine-3-kinase activity [MF], fructoselysine metabolic process [BP], paraxial mesoderm structural organization [BP], neural plate mediolateral regionalization [BP]
CG_ff_promoter_p_RM_12_223_15			4	0.5	3.16E-04	ADRB1, SLC5A5, ADRA2C, AP2M1	clathrin coat of coated pit [CC], alpha-2A adrenergic receptor binding [MF], negative regulation of smooth muscle contraction [BP], epinephrine binding [MF], cellular response to gonadotropin stimulus [BP]
CG_ff_promoter_p_RM_12_392_6			1	0.5	1.52E-04	GTPBP3	tRNA modification [BP]
CG_ff_promoter_p_RM_12_7_7			1	0.5	1.55E-04	PTS, CSGALNACT2, PIK3CA, TARBP2	dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP], 1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex [CC], chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP], glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [MF], hypomethylation of CpG island [BP], miRNA loading onto RISC involved in gene silencing by miRNA [BP], 6-pyruvoyltetrahydropterin synthase activity [MF]
CG_ff_promoter_p_RM_12_311_6			2	1.0	4.56E-05	RPS15	ribosomal small subunit export from nucleus [BP]
CG_ff_promoter_p_RM_12_237_16			2	0.5	4.67E-04	HTRA2	pentacyclic triterpenoid metabolic process [BP]
CG_ff_promoter_p_RM_12_139_10			1	0.5	4.72E-05	SDSL, PPARA, PNPLA3	regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter [BP], regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], diolein transacylation activity [MF], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP], mono-olein transacylation activity [MF], L-threonine ammonia-lyase activity [MF]
CG_ff_promoter_p_RM_12_177_10			3	0.5	1.95E-04	MPP5, IKZF1	positive regulation of neutrophil differentiation [BP], protein localization to myelin sheath abaxonal region [BP]
CG_ff_promoter_p_RM_12_15_11			2	1.0	6.22E-05	P2RX2	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP]
CG_ff_promoter_p_RM_14_64_5			4	0.5	1.30E-04	PDXK, MDM2	cellular response to vitamin B1 [BP], pyridoxal 5'-phosphate salvage [BP], cellular response to UV-C [BP], lithium ion binding [MF], pyridoxal kinase activity [MF], pyridoxal phosphate biosynthetic process [BP]
CG_ff_promoter_p_RM_12_195_7			3	0.5	2.80E-04	BMPR2, MSX1	positive regulation of BMP signaling pathway [BP], BMP signaling pathway [BP]
CG_ff_promoter_p_RM_12_315_6			2	0.5	2.58E-04	CRHR1, IGF1R	G-protein alpha-subunit binding [MF]
CG_ff_promoter_p_RM_12_306_13			2	0.5	2.96E-04	NCS1, CCND2	positive regulation of exocytosis [BP], cyclin-dependent protein kinase holoenzyme complex [CC]
CG_ff_promoter_p_RM_12_230_15			4	0.5	2.76E-04	ACSBG2, ZIC1, BMP1	spinal cord development [BP], cell differentiation [BP]
CG_ff_promoter_p_RM_14_17_3			3	0.5	4.01E-04	SART1, SLC5A2, SOX2	positive regulation of cytotoxic T cell differentiation [BP], low-affinity glucose:sodium symporter activity [MF], detection of mechanical stimulus involved in equilibrioception [BP]
CG_ff_promoter_p_RM_12_390_7			2	0.5	2.26E-04	TMX1	arsenate reductase (thioredoxin) activity [MF]
CG_ff_promoter_p_RM_12_408_18			3	0.5	2.18E-04	PFKFB3	fructose metabolic process [BP]
CG_ff_promoter_p_RM_12_189_25			3	0.5	3.72E-04	FOXL1, SLC25A27	visceral mesoderm-endoderm interaction involved in midgut development [BP], reduction of mitochondrial calcium ion concentration [BP], cartilage development [BP]
CG_ff_promoter_p_RM_12_290_6			1	0.5	1.70E-04	INPP5J	phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [MF]
CG_ff_promoter_p_RM_12_51_12			4	1.0	5.00E-05	THBS1	negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [BP], negative regulation of nitric oxide mediated signal transduction [BP], negative regulation of cGMP-mediated signaling [BP], positive regulation of eukaryotic cell surface binding [BP], negative regulation of dendritic cell antigen processing and presentation [BP]
CG_ff_promoter_p_RM_14_18_5			3	0.5	2.63E-04	MLL	positive regulation of cellular response to drug [BP]
CG_ff_promoter_p_RM_12_72_5			1	0.5	6.29E-05	ACO2	citrate hydro-lyase (cis-aconitate-forming) activity [MF], 3 iron, 4 sulfur cluster binding [MF], isocitrate hydro-lyase (cis-aconitate-forming) activity [MF]
CG_ff_promoter_p_RM_12_183_12			4	0.5	4.48E-04	FZD1, IGF1R, DDX20, ZAK, NPR1, SRC, TTL, NTRK1, AK4, MCM2, FADD, P2RX2, ROR1, DNAH14	axonogenesis [BP], protein tyrosine kinase activity [MF], extrinsic apoptotic signaling pathway [BP], negative regulation of extrinsic apoptotic signaling pathway [BP], ATP binding [MF], transmembrane receptor protein tyrosine kinase activity [MF]
CG_ff_promoter_p_RM_12_335_5			1	0.5	8.47E-05	GNAS	post-embryonic body morphogenesis [BP]
CG_ff_promoter_p_RM_12_337_9			2	0.5	1.04E-04	WNT16, CDKN1A, BAMBI, HNRNPAB	cellular senescence [BP], epithelial to mesenchymal transition [BP], stress-induced premature senescence [BP], frizzled binding [MF]
CG_ff_promoter_p_RM_16_10_13			2	0.5	5.33E-04	SGPL1, CHD7, TAL2, NR4A3, ID4, ALMS1, MAN2A1, SLIT2, HES1, GATA3, PRDM16	multicellular organism growth [BP], regulation of multicellular organism growth [BP], palate development [BP], ear development [BP], telencephalon development [BP], semicircular canal morphogenesis [BP], negative regulation of cellular response to growth factor stimulus [BP], negative regulation of oligodendrocyte differentiation [BP], in utero embryonic development [BP], pharyngeal system development [BP], metanephros development [BP], regulation of fat cell differentiation [BP], hemopoiesis [BP], fat cell differentiation [BP]
CG_ff_promoter_p_RM_14_16_6			3	0.5	3.93E-04	TBC1D25, WAC	regulation of autophagic vacuole maturation [BP], histone H2B conserved C-terminal lysine ubiquitination [BP]
CG_ff_promoter_p_RM_12_300_10			2	0.5	7.24E-05	FXYD5, PTDSS2	CDP-diacylglycerol-serine O-phosphatidyltransferase activity [MF], negative regulation of calcium-dependent cell-cell adhesion [BP]
CG_ff_promoter_p_RM_14_83_4			1	0.5	4.91E-04	USP10, EHMT1	p53 binding [MF]
CG_ff_promoter_p_RM_14_9_15			4	0.5	5.50E-04	SMG7, YY1, ASNA1, BIRC7, EIF2B2, PRKAA2, AFTPH, TLX1, SPNS1, SLAIN2, RCOR1, DYRK2, SEC23IP, ADCYAP1R1, SGPL1, INTS10, CHD7, MPZL1, MST4, SOX11, ARF1, FAT4, ALMS1, SLIT2, FOXF2, TMEM57, CUL1, POU3F3, POU3F2, GREM1, RAB5A, PSMG2, TAL2, NR4A3, NR4A1, CNOT6, ATP1B3, SLC25A5, SERPINB8, FPGS, GLTSCR2, DYNC1H1, FMN2, GATA3, SUV420H2, PRDM16, ASPSCR1, LMTK2, CAMSAP2, TAB2, ID4, AGO4, AKAP9, IPO9, PKNOX2, NDST1, HES1, PITPNC1, SKIL, MVP	midbrain development [BP], ureteric bud formation [BP], brain development [BP], regulation of fat cell differentiation [BP], intracellular membrane-bounded organelle [CC], intracellular transport [BP], cell migration involved in sprouting angiogenesis [BP], forebrain ventricular zone progenitor cell division [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], development of primary female sexual characteristics [BP], multicellular organism growth [BP], protein binding [MF], negative regulation of cellular response to growth factor stimulus [BP], kidney development [BP], oligodendrocyte development [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF], organ morphogenesis [BP], transport [BP], central nervous system development [BP], negative regulation of monocyte chemotaxis [BP], negative regulation of leukocyte chemotaxis [BP], glial cell development [BP], palate development [BP], semicircular canal morphogenesis [BP], telencephalon development [BP], forebrain development [BP], sequence-specific DNA binding [MF], metanephros development [BP]
CG_ff_promoter_p_RM_12_333_8			3	0.5	1.95E-04	OVOL1	mesoderm development [BP]
CG_ff_promoter_p_RM_14_81_3			2	0.5	2.30E-04	HTR6, ATP9B, TNFAIP3, PRKAA2, AMOTL1	negative regulation of toll-like receptor 3 signaling pathway [BP], [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [MF], negative regulation of osteoclast proliferation [BP], negative regulation of CD40 signaling pathway [BP], negative regulation of toll-like receptor 5 signaling pathway [BP], [acetyl-CoA carboxylase] kinase activity [MF], B-1 B cell homeostasis [BP], aminophospholipid transporter activity [MF], negative regulation of acetylcholine secretion [BP], establishment of cell polarity involved in ameboidal cell migration [BP], negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [BP], negative regulation of gamma-aminobutyric acid secretion [BP], tolerance induction to lipopolysaccharide [BP], negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [BP]
CG_ff_promoter_p_RM_14_39_7			2	0.5	1.94E-04	HEXB, SMAD4	transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [MF], male courtship behavior [BP], branching involved in ureteric bud morphogenesis [BP]
CG_ff_promoter_p_RM_12_151_4			1	0.5	1.87E-04	ALPL, ADORA1	positive regulation of nucleoside transport [BP], cementum mineralization [BP], negative regulation of neurotrophin production [BP]
CG_ff_promoter_p_RM_16_6_2			1	0.5	2.98E-04	PCDHB14, PCDHB8, PCDHB15, PCDHB4, PCDHB13	homophilic cell adhesion [BP], calcium-dependent cell-cell adhesion [BP], calcium ion binding [MF], synapse assembly [BP], cell adhesion [BP]
CG_ff_promoter_p_RM_14_113_3			3	0.5	4.56E-04	NOG, YBX1, GIPR	negative regulation of cytokine activity [BP], fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], gastric inhibitory peptide receptor activity [MF], negative regulation of striated muscle cell differentiation [BP], regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP]
CG_ff_promoter_p_RM_14_35_3			3	0.5	2.79E-04	RIPK1	regulation of ATP:ADP antiporter activity [BP]
CG_ff_promoter_p_RM_12_28_5			2	1.0	8.07E-05	RIMKLB, OS9	Hrd1p ubiquitin ligase complex [CC], citrate-L-glutamate ligase activity [MF]
CG_ff_promoter_p_RM_14_12_6			2	0.5	4.46E-04	TCF7, SPATA18, YAP1, SOX11	regulation of stem cell proliferation [BP], hippo signaling cascade [BP], embryonic digestive tract morphogenesis [BP], intracellular membrane-bounded organelle [CC]
CG_ff_promoter_p_RM_14_101_7			4	0.5	4.80E-04	ZFPM1	megakaryocyte differentiation [BP]
CG_ff_promoter_p_RM_12_398_11			1	0.5	1.68E-04	BCAM, FOXC1, FOXB1	cell migration in diencephalon [BP], laminin receptor activity [MF], somitogenesis [BP], mammillary body development [BP], DNA binding, bending [MF], inferior colliculus development [BP], mammillothalamic axonal tract development [BP]
CG_ff_promoter_p_RM_14_10_5			4	0.5	5.57E-04	FGFRL1, CPSF4, FZD1, SGPL1, CHD7, SOX11, TFAP2C, ALMS1, MKL2, SLIT2, FOXF2, TMEM57, CUL1, POU3F3, PABPN1, GREM1, NR4A3, MAN2A1, FPGS, USP15, GATA3, PRDM16, HES1, KDM1A	ureteric bud formation [BP], BMP signaling pathway [BP], regulation of fat cell differentiation [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], ventricular septum morphogenesis [BP], hard palate development [BP], modulation by virus of host cellular process [BP], in utero embryonic development [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription [MF], modification by virus of host mRNA processing [BP], negative regulation of cellular response to growth factor stimulus [BP], kidney development [BP], establishment of planar polarity [BP], organ morphogenesis [BP], heart morphogenesis [BP], brain development [BP], central nervous system development [BP], negative regulation of monocyte chemotaxis [BP], negative regulation of leukocyte chemotaxis [BP], enhancer sequence-specific DNA binding [MF], palate development [BP], semicircular canal morphogenesis [BP], telencephalon development [BP], positive regulation of stem cell proliferation [BP], metanephros development [BP], ventricular septum development [BP]
CG_ff_promoter_p_RM_12_35_6			2	1.0	9.72E-05	RGR, OR4A15, CHST8, FPGS, GPR160, XPR1, GHRHR	central nervous system development [BP], tetrahydrofolylpolyglutamate synthase activity [MF], G-protein coupled receptor activity [MF]
CG_ff_promoter_p_RM_12_76_8			2	0.5	1.49E-04	BARHL1, NIPBL	sensory perception of sound [BP]
CG_ff_promoter_p_RM_14_85_4			2	0.5	4.62E-04	SLC2A4, CTDP1, POLR3D	amylopectin biosynthetic process [BP], DNA-directed RNA polymerase activity [MF]
CG_ff_promoter_p_RM_12_155_4			2	0.5	6.70E-05	PDE8A, NTF3	glial cell fate determination [BP], phosphorelay response regulator activity [MF]
CG_ff_promoter_p_RM_12_157_7			2	0.5	1.50E-04	ITCH, PPIA, IRAK2	nucleotide-binding oligomerization domain containing signaling pathway [BP], entry into host cell [BP]
CG_ff_promoter_p_RM_12_103_22			4	0.5	3.82E-04	E2F4, NR2E1, FOSL2, CDKN1A	G1 phase of mitotic cell cycle [BP], positive regulation of fibroblast proliferation [BP], amygdala development [BP], cyclin-dependent protein kinase activating kinase activity [MF]
CG_ff_promoter_p_RM_12_112_4			5	0.5	4.56E-04	TRIB2	negative regulation of interleukin-10 biosynthetic process [BP]
CG_ff_promoter_p_RM_12_299_6			2	0.5	1.49E-04	FOXL1	visceral mesoderm-endoderm interaction involved in midgut development [BP]
CG_ff_promoter_p_RM_14_87_3			2	0.5	3.80E-04	ELF3, ARID1B, KDM1A	regulation of primitive erythrocyte differentiation [BP], transcription coactivator activity [MF]
CG_ff_promoter_p_RM_12_71_12			3	1.0	1.46E-04	ASS1, EPHX2	10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [MF], argininosuccinate synthase activity [MF], stilbene catabolic process [BP], 4-nitrophenylphosphatase activity [MF]
CG_ff_promoter_p_RM_14_14_4			2	0.5	2.58E-04	THBS1, EGFR	negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [BP], positive regulation of protein kinase B signaling cascade [BP], negative regulation of cGMP-mediated signaling [BP], negative regulation of nitric oxide mediated signal transduction [BP], positive regulation of eukaryotic cell surface binding [BP], negative regulation of dendritic cell antigen processing and presentation [BP]
CG_ff_promoter_p_RM_12_401_10			5	0.5	3.02E-04	ID4	fat cell differentiation [BP]
CG_ff_promoter_p_RM_12_132_6			1	0.5	5.23E-05	IGF1R	inactivation of MAPKK activity [BP]
CG_ff_promoter_p_RM_14_33_2			3	0.5	3.24E-04	JMY, LNPEP	'de novo' actin filament nucleation [BP], Arp2/3 complex-mediated actin nucleation [BP], early endosome lumen [CC], actin polymerization-dependent cell motility [BP]
CG_ff_promoter_p_RM_18_1_2			1	0.5	2.08E-04	TGFBR1, SP1	embryonic skeletal system development [BP], blastocyst development [BP]
CG_ff_promoter_p_RM_18_3_2			2	1.0	9.53E-05	RIMS1	calcium ion-dependent exocytosis of neurotransmitter [BP]
CG_ff_promoter_p_RM_12_275_9			2	0.5	4.65E-04	ANAPC11, BUB3, MTRR, TFAP2C	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], [methionine synthase] reductase activity [MF], spindle assembly checkpoint [BP], mitotic cell cycle spindle assembly checkpoint [BP]
CG_ff_promoter_p_RM_14_70_8			2	1.0	8.29E-05	SKI	histone deacetylase inhibitor activity [MF]
CG_ff_promoter_p_RM_12_412_7			3	0.5	2.64E-04	COL8A1, SOX1, NTRK1, SOX2	camera-type eye morphogenesis [BP], forebrain neuron differentiation [BP], neurotrophin p75 receptor binding [MF], lens morphogenesis in camera-type eye [BP]
CG_ff_promoter_p_RM_14_103_4			2	0.5	2.86E-04	STT3A	co-translational protein modification [BP]
CG_ff_promoter_p_RM_12_302_14			3	0.5	3.47E-04	YTHDC2, LANCL2	positive regulation of abscisic acid mediated signaling pathway [BP], ATP-dependent helicase activity [MF]
CG_ff_promoter_p_RM_12_414_3			2	0.5	3.62E-04	ZFPM1	mitral valve formation [BP], negative regulation of interleukin-4 biosynthetic process [BP], transcriptional activation by promoter-enhancer looping [BP], tricuspid valve formation [BP], negative regulation of mast cell differentiation [BP]
CG_ff_promoter_p_RM_12_1_16			2	1.0	1.75E-04	DDX25	spermatid development [BP]
CG_ff_promoter_p_RM_14_31_5			2	0.5	2.61E-04	NR2F2, SOX11	radial pattern formation [BP], positive regulation of lens epithelial cell proliferation [BP], positive regulation of hippo signaling cascade [BP]
CG_ff_promoter_p_RM_14_89_3			1	0.5	2.64E-04	STAG3	transverse filament [CC]